The hydrochloride salt of benazepril, a carboxyl-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, benazepril is metabolized to its active form benazeprilat. Benazeprilat competitively binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the potent vasoconstrictive actions of angiotensin II, resulting in vasodilation. Benazeprilat also decreases angiotensin II-induced aldosterone secretion by the adrenal cortex, which leads to an increase in sodium excretion and subsequently increases water outflow.


The hydrochloride salt form of quinapril, a prodrug and non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Quinapril is hydrolized into its active form quinaprilat, which binds to and inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This abolishes the potent vasoconstrictive actions of angiotensin II and leads to vasodilatation. Quinapril also causes a decrease in angiotensin II-induced aldosterone secretion by the adrenal cortex, thereby promoting diuresis and natriuresis, and increases bradykinin levels.


The hydrochloride salt form of lomefloxacin, a synthetic broad-spectrum fluoroquinolone with antibacterial activity. Lomefloxacin hydrochloride inhibits DNA gyrase, a type II topoisomerase involved in the induction or relaxation of supercoiling during DNA replication. This inhibition leads to a decrease in DNA synthesis during bacterial replication, resulting in cell growth inhibition and eventually cell lysis.


The hydrochloride salt form of azelastine, a phthalazinone derivative with antihistaminergic activity. Azelastine hydrochloride competes with histamine for the H1 receptor, thereby diminishing the actions of histamine on effector cells and decreasing the histamine-mediated symptoms of allergic reaction, such as bronchoconstriction, vasodilation, increased capillary permeability and spasmodic contractions of gastrointestinal smooth muscle.


The hydrochloride salt form of mebeverine, an orally bioavailable reserpine derivative and anticholinergic agent, with spasmolytic activity. Upon administration, mebeverine targets, binds to and blocks the muscarinic receptors on smooth muscle cells in target tissues, such as the gastrointestinal (GI) tract, uterus, gallbladder and bladder. This prevents smooth muscle contraction and relaxes smooth muscle. Additionally, this may prevent spasms, ease pain and cramps in the GI tract and improve incontinence. In addition, mebeverine stabilizes excitable membranes by decreasing the permeability of ion channels and preventing intracellular calcium accumulation. This agent also blocks noradrenaline reuptake by sympathetic nerve endings and exerts a local anesthetic effect.


The hydrochloride salt form of paroxetine, a phenylpiperidine derivative and a selective serotonin reuptake inhibitor (SSRI) with antidepressant and anxiolytic properties. Paroxetine binds to the pre-synaptic serotonin transporter complex resulting in negative allosteric modulation of the complex thereby blocking reuptake of serotonin by the pre-synaptic transporter. Inhibition of serotonin recycling enhances serotonergic function through serotonin accumulation in the synaptic cleft, resulting in long-term desensitization and downregulation of 5HT1 (serotonin) receptors and leading to symptomatic relief of depressive illness.


A synthetic allylamine derivative structurally related to naftifine, antifungal Terbinafine Hydrochloride blocks ergosterol biosynthesis by inhibition of squalene epoxidase, part of the sterol synthesis pathway for the fungal cell membrane. Highly lipophilic, it tends to accumulate in skin, nails, and fatty tissues. Terbinafine is active against dermatophytes. (NCI04)


A bifunctional alkylating agent and phenylalanine derivative of nitrogen mustard. Melphalan hydrochloride is converted into highly reactive ethylenimmonium intermediates that induce covalent guanine N7-N7 intra- and inter-crosslinks and alkylation of adenine N3 of DNA. This agent also alkylates RNA and protein structures. As a result RNA transcription and protein synthesis are inhibited, ultimately leading to cell growth arrest and/or death.


The hydrochloride salt of a dihydropyridine derivative with diuretic and antihypertensive activity. Cicletanine exerts thiazide-like diuretic activity. In addition, this agent inhibits protein kinase C (PKC) and is able to reverse vasoconstriction through the inhibition of PKC-mediated inhibition of Na/K-ATPase phosphorylation.


The hydrochloride salt form of tacrine, an aminoacridine derivative with cognitive stimulating property. Although the mechanism of action has not been fully elucidated, tacrine hydrochloride may bind reversibly to cholinesterase, acetylcholinesterase as well as butyrylcholinesterase, thereby decreasing the breakdown of acetylcholine, and prolonging synaptic actions as well as increased release of acetylcholine. In addition, this agent inhibits monoamine oxidase (MAO) and may inhibit the reuptake of catecholamines and serotonin. Finally, a novel mechanism of action studied in animal models suggests tacrine to attenuate the production of interleukin-1beta in the hippocampus and blood, thereby producing central and peripheral anti-inflammatory effects that may play a role in Alzheimer's disease.


The hydrochloride salt form of levocabastine, a synthetic piperidine derivative with antihistaminic properties. Levocabastine is a second generation histamine-1 receptor antagonist. When applied locally to the eye as a topical solution, this agent reduces itching, rhinorrhea, and symptoms of allergic rhinitis or conjunctivitis.


A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.


Anhydrous from of tacrolimus, a macrolide isolated from Streptomyces tsukubaensis. Tacrolimus binds to the FKBP-12 protein and forms a complex with calcium-dependent proteins, thereby inhibiting calcineurin phosphatase activity and resulting in decreased cytokine production. This agent exhibits potent immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation. Tacrolimus possesses similar immunosuppressive properties to cyclosporine, but is more potent.


The hydrochloride salt form of tropisetron, a selective, competitive serotonin 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist, with antinauseant and antiemetic activities. Tropisetron competitively binds to and blocks the action of serotonin at 5HT3 receptors peripherally on vagus nerve terminals located in the gastrointestinal (GI) tract as well as centrally in the chemoreceptor trigger zone (CTZ) of the area postrema of the central nervous system (CNS). This results in the suppression of chemotherapy- and radiotherapy-induced nausea and vomiting.


The hydrochloride salt of a semi-synthetic, beta-lactamase-resistant, fourth-generation cephalosporin antibiotic derived from an Acremonium fungal species with broad-spectrum bactericidal activity. Administered parenterally, cefepime inhibits bacterial cell wall synthesis by binding to and inactivating penicillin-binding proteins (PBP) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity, resulting in a reduction of bacterial cell wall stability and cell lysis. This agent is more active against a variety of Gram-positive pathogens compared to third-generation cephalosporins.


The hydrochloride salt form of dorzolamide, an inhibitor of carbonic anhydrase, a zinc-containing enzyme that catalyzes the rapid conversion of carbon dioxide and water into carbonic acid, protons and bicarbonate ions. Distributed throughout many cells and tissues, various carbonic anhydrases play important roles in mineral and metabolic homeostasis. (NCI04)


The hydrochloride salt form of moexipril, a prodrug and non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Moexipril hydrochloride is hydrolized into its active form moexiprilat, which competitively inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the actions of the potent vasoconstrictor angiotensin II and leads to vasodilatation. It also prevents angiotensin II-induced aldosterone secretion by the adrenal cortex, thereby promoting diuresis and natriuresis. Moexipril hydrochloride also directly suppresses renin release.


The hydrochloride salt form of nalmefene, a naltrexone analogue with opioid antagonistic property. Nalmefene antagonizes the effects of opioids by competing for the opioid receptors in the CNS. This results in reversal of the effects of the opioids, including reversal of analgesia, euphoria, respiratory depression, hypotension, sedation and physical dependence.


The hydrochloride salt of valacyclovir. Valacyclovir is an acyclovir prodrug that, after metabolization, inhibits viral DNA replication. It is used in the management of herpes simplex and varicella zoster infections, as well as prophylactically for human cytomegalovirus infections.


A synthetic derivative of phenylpiperazine and chemically unrelated to selective serotonin reuptake inhibitors, tricyclics, tetracyclics, or monoamine oxidase inhibitors (MAOI), antidepressant Nefazadone Hydrochloride antagonizes central 5-HT2 receptors and inhibits reuptake of serotonin and norepinephrine. (NCI04)


A second generation bisphosphonate and synthetic analog of pyrophosphate with anti-bone-resorption activity. Alendronic acid binds to and inhibits the activity of farnesyl pyrophosphate synthetase, an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids, donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which are important in the process of osteoclast turnover. As a result, bone resorption and turnover are reduced.


The sodium salt form of a benzimidazole with selective and irreversible proton pump inhibitor activity. In the acidic compartment of parietal cells, omeprazole is protonated and converted into the active achiral sulfenamide; the active sulfenamide forms one or more covalent disulfide bonds with the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase), thereby inhibiting its activity and the parietal cell secretion of H+ ions into the gastric lumen, the final step in gastric acid production. H+/K+ ATPase is an integral membrane protein of the gastric parietal cell.


The sulfate form of cefpirome, a semisynthetic, broad-spectrum, fourth-generation cephalosporin with antibacterial activity. Cefpirome binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are enzymes involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This results in the weakening of the bacterial cell wall and causes cell lysis.


The anhydrous form of docetaxel, a semisynthetic side-chain analogue of paclitaxel with antineoplastic property. Docetaxel binds specifically to the beta-tubulin subunit of microtubules and thereby antagonizes the disassembly of the microtubule proteins. This results in the persistence of aberrant microtubule structures and results in cell-cycle arrest and subsequent cell death.


The acetate salt of a synthetic cyclic octapeptide analogue of somatostatin. Lanreotide binds to somatostatin receptors (SSTR), specifically SSTR-2 and also to SSTR-5 with a lesser affinity. However, compare with octreotide, this agent is less potent in inhibiting the release of growth hormone from the pituitary gland. Furthermore, lanreotide has an acute effect on decreasing circulating total and free insulin-like growth factor 1 (IGF-I). This agent is usually given as a prolonged-release microparticle or Autogel formulation for the treatment of acromegaly and to relieve the symptoms of neuroendocrine tumors.


The hydrochloride salt form of cefotiam, a third-generation, semi-synthetic, beta-lactam cephalosporin antibiotic with antibacterial activity. Cefotiam binds to penicillin-binding proteins (PBPs), transpeptidases that are responsible for crosslinking of peptidoglycan. By preventing crosslinking of peptidoglycan, cell wall integrity is lost and cell wall synthesis is halted.


The fumarate salt form of formoterol, a long-acting and selective sympathomimetic beta-receptor agonist with bronchodilator activity. Formoterol fumarate binds beta 2 adrenergic receptors in bronchial smooth muscle and stimulates intracellular adenyl cyclase, thereby increasing the production of cyclic adenosine monophosphate (cAMP). Increased cAMP levels cause relaxation of bronchial smooth muscle, improve mucociliary clearance and reduce mediator substance release in inflammatory cells, especially from mast cells. (NCI05)


The hydrochloride salt of an analogue of the antimetabolite nucleoside deoxycytidine with antineoplastic activity. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.


Harpagophytum procumbens root preparation

An herb obtained from the plant Harpagophytum procumbens. Devil's claw has been used as a tonic, as a hypoglycemic, to cleanse the lymph system, and in the treatment of arthritis, rheumatism, and skin cancer. This agent may have anti-inflammatory and analgesic properties, possibly due to the presence of antioxidants, phenols, tannins, triterpenoids and volatile oils. (NCI04)


The lithium salt form of benzoic acid with diuretic and urinary antiseptic activity. Lithium benzoate exerts natriuretic activity and disinfects the urinary tract, but has considerable toxicity.


saw palmetto is the common name for Serenoa repens; an extract made from the berries of this shrub is used to treat and strengthen the male reproductive system; particularly beneficial for enlargement of the prostate gland.


An herbal product made from the dried root of the several perennial trailing vines of the genus Smilax, native to Central America. Sarsaparilla, used commonly as a flavoring, contains steroidal saponins, numerous phytosterols and flavonoids.


A sterile, non-pyrogenic pulmonary surfactant and extract composed of natural porcine lung surfactant consisting of 99% polar lipids, mainly phospholipids, and 1% hydrophobic low molecular weight proteins, including the surfactant associated proteins SP-B and SP-C, that can be used to replace and mimic endogenous pulmonary surfactant. Upon intratracheal administration, poractant alfa compensates for the deficiency of endogenous lung surfactant and restores surface activity to the lungs. This reduces surface tension at the air-liquid interface of the alveoli during ventilation and stabilizes the alveoli against collapse at resting transpulmonary pressures. This may improve poor lung expansion, inadequate gas exchange, and may improve oxygenation.


A levo isomer of menthol, an organic compound made synthetically or obtained from peppermint or mint oils with flavoring and local anesthetic properties. When added to pharmaceuticals and foods, menthol functions as a fortifier for peppermint flavors. It also has a counterirritant effect on skin and mucous membranes, thereby producing a local analgesic or anesthetic effect.


A hydrochloride salt form of tromantadine, a cyclic amine with activity against herpes simplex virus. Tromantadine inhibits absorption of virions to cell surfaces, as well as penetration and uncoating of the virus.


The hydrochloride salt form of tizanidine, an imidazoline derivative structurally similar to clonidine and an adrenergic agonist with muscle relaxant property. Tizanidine stimulates alpha-2 adrenergic receptors in the central nervous system, thereby inhibiting presynaptic release of norepinephrine and increasing the inhibitory effect on alpha motor neurons and motor reflexes. Tizanidine exerts some activity at the postsynaptic excitatory amino acid receptors and imidazoline receptors which may contribute to the overall reduction in facilitation of spinal motor neurons. Overall, tizanidine hydrochloride causes muscle relaxation, reduces spasticity and antinociceptive effects.


The hydrochloride salt form of fexofenadine, a carboxylated metabolic derivative of terfenadine and second generation, long-lasting selective histamine H1 receptor antagonist, with antihistaminic activity. Upon administration, fexofenadine competitively binds of peripheral H1-receptors in the gastrointestinal (GI) tract, blood vessels, and bronchial smooth muscle. This prevents binding of histamine to peripheral H1-receptors and prevents their activation. This prevents a histamine-mediated allergic reaction. Fexofenadine does not cross the blood-brain-barrier (BBB).


A sodium salt of rifamycin, an antibiotic produced by Streptomyces mediterranei which is used to treat mycobacterium infections.


The magnesium salt form of a benzimidazole with selective and irreversible proton pump inhibitor activity. In the acidic compartment of parietal cells, omeprazole is protonated and converted into the active achiral sulfenamide; the active sulfenamide forms one or more covalent disulfide bonds with the proton pump hydrogen-potassium adenosine triphosphatase (H+/K+ ATPase), thereby inhibiting its activity and the parietal cell secretion of H+ ions into the gastric lumen, the final step in gastric acid production. H+/K+ ATPase is an integral membrane protein of the gastric parietal cell.


The hydrochloride salt of tamsulosin, a sulfonamide derivative with adrenergic antagonist activity. Tamsulosin selectivity binds to and blocks the activity of alpha1 adrenoreceptors in the human prostate and bladder neck; blockade of these adrenoceptors can cause smooth muscle in the prostate and bladder neck to relax, resulting in an improvement in urinary flow rate.


The anhydrous, sodium salt form of sulfuric acid. Sodium sulfate anhydrous disassociates in water to provide sodium ions and sulfate ions. Sodium ion is the principal cation of the extracellular fluid and plays a large part in the therapy of fluid and electrolyte disturbances. Sodium sulfate anhydrous is an electrolyte replenisher and is used in isosmotic solutions so that administration does not disturb normal electrolyte balance and does not lead to absorption or excretion of water and ions.


The hydrochloride salt of ropivacaine, a local anesthetic of the amide type with analgesic activity. Ropivacaine binds to voltage-gated sodium ion channels in the neuronal membrane, thereby preventing the permeability of sodium ions and resulting in a stabilization of the neuronal membrane and inhibition of depolarization; nerve impulse generation and propagation are blocked, resulting in a reversible loss of sensation.


The hydrochloride salt form of remifentanil, a synthetic anilidopiperidine derivative and short-acting opiate agonist with analgesic and anesthetic properties. Remifentanil selectively binds to and activates the mu-opioid receptor, thereby producing analgesia, respiratory depression, miosis, reduced gastrointestinal motility, and euphoria.


The hydrochloride salt form of ropinirole, a non-ergot dopamine agonist with antiparkinsonian property. Acting as a substitute for dopamine, ropinirole hydrochloride binds to and activates dopamine D2 and D3 receptors within the caudate putamen in the brain, thereby improving motor function.


The hydrochloride salt form of butenafine, a synthetic benzylamine derivative with fungicidal properties. Butenafine hydrochloride interferes with the biosynthesis of ergosterol, an important component of fungal cell membranes, by inhibiting the epoxidation of squalene. This alters fungal membrane permeability and causes growth inhibition. Butenafine hydrochloride is active against a number of dermatophytes, including Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis, Sporothrix schenckii, and yeasts, including Candida albicans and C. parapsilosis.


The hydrochloride salt of a piperidine derivative with neurocognitive-enhancing activity. Donepezil reversibly inhibits acetylcholinesterase, thereby blocking the hydrolysis of the neurotransmitter acetylcholine and, consequently, increasing its activity. This agent may improve neurocognitive function in Alzheimer's disease, reduce sedation associated with opioid treatment of cancer pain, and improve neurocognitive function in patients who have received radiation therapy for primary brain tumors or brain metastases.


Haemophilus influenzae b (Ross strain) capsular polysaccharide meningococcal protein conjugate vaccine


The hydrochloride salt form of olopatadine, a dual action selective histamine H1 receptor antagonist and mast cell stabilizer with anti-allergic activity. Olopatadine stabilizes mast cells and prevents histamine release from mast cells. In addition, this agent also blocks histamine H1 receptors, thereby preventing histamine from binding to these receptors. Both actions prevent the effects of histamine on capillaries, bronchial smooth muscle, and gastrointestinal (GI) smooth muscle, including histamine-induced vasodilation, increased capillary permeability, bronchoconstriction, and spasmodic contraction of GI smooth muscle. This drug also prevents histamine-induced pain and itching of mucous membranes.


The nitrate salt form of sertaconazole, a synthetic imidazole derivative with antifungal property. Sertaconazole nitrate inhibits fungal cytochrome P-450 sterol C-14 alpha-demethylation, resulting in the accumulation of fungal 14 alpha-methyl sterols and the inhibition of ergosterol synthesis, an essential component of the cell membrane of fungi. This leads to a disruption of cell membrane permeability and leakage of adenine triphosphate (ATP) and other constituents from fugal cells.


The hydrochloride salt of a synthetic quinazoline derivative, Anagrelide Hydrochloride reduces platelet production through a decrease in megakaryocyte maturation. Anagrelide inhibits cyclic AMP phosphodiesterase, as well as ADP- and collagen-induced platelet aggregation. At therapeutic doses, it does not influence white cell counts or coagulation parameters. Anagrelide is used for treatment of essential thrombocythemia to reduce elevated platelet counts and the risk of thrombosis. (NCI04)


The potassium salt form of propicillin, a semisynthetic acid-stable penicillin with antibacterial activity. Propicillin binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. This interrupts bacterial cell wall synthesis and results in the weakening of the bacterial cell wall, eventually causing cell lysis.


pantoprazole (as pantoprazole sodium sesquihydrate)


The hydrochloride salt form of doxycycline exhibiting antimicrobial activity. Doxycycline blocks binding of aminoacyl-tRNA to the mRNA-ribosome complex, thereby inhibiting protein synthesis. In addition, this agent has exhibited inhibition of collagenase activity. (NCI)


The round, black berries of the flowering shrub Vitex agnus-castus, native to Mediterranean countries and Asia. Chaste berries contain glycosides, flavonoids, alkaloids, monoterpenes, and sesquiterpenes. Chaste berries are considered as a reproductive tonic herb.


A triterpene-containing herb isolated from the roots and rhizomes of the plant Cimicifuga racemosa (also known as Actaea racemosa). While the mechanism of action of black cohosh is not completely understood, it appears to act as a selective estrogen receptor modulator. In vitro, this preparation has been shown to induce cell cycle arrest and caspase-dependent apoptosis of estrogen-sensitive breast cancer cells. (NCI04)


The hydrochloride salt of memantine, a low-affinity, voltage-dependent, noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. Memantine binds to and inhibits cation channels of glutamanergic NMDA receptors located in the central nervous system (CNS), preventing the prolonged influx of calcium ions and the associated neuronal excitotoxicity, and thereby potentially enhancing cognitive function. Memantine is also a 5-hydroxytryptamine type 3 (5HT3) receptor and nicotinic receptor antagonist.


The hydrochloride salt form of naratriptan, a sulfonamide with selective serotonin (5-HT) 1 receptor agonistic activity and anti-migraine property. Naratriptan hydrochloride binds selectively and with high affinity to the 5-HT1D and 5-HT1B receptor subtypes. Activation of these 5-HT1D/B receptors located on intracranial blood vessels leads to vasoconstriction and provides relief of migraine headaches. Naratriptan hydrochloride may also exerts its effect by stimulation of 5-HT1D/1B receptors on sensory nerve endings in the trigeminal system thereby decreasing the release of pro-inflammatory neuropeptides.


The hydrochloride salt of pramipexole, a benzothiazole derivative. As a nonergot dopamine agonist, pramipexole binds to D2 and D3 dopamine receptors in the striatum and substantia nigra of the brain. Compared to other dopamine agonists, the use of this agent may be associated with fewer dyskinetic side effects in treated subjects. (NCI04)


A species of Saccharomyces that is used as a PROBIOTIC, such as in the treatment of DIARRHEA and PSEUDOMEMBRANOUS ENTEROCOLITIS associated with CLOSTRIDIUM INFECTIONS.


A substance derived from the plant Ginkgo biloba. Ginkgo biloba leaf extract contains potent anti-oxidants and substances believed to improve blood flow to the brain and peripheral tissues. Ginkgo biloba exocarp polysaccharides (GBEP) can inhibit proliferation and induce apoptosis and differentiation of tumor cells. As a medicinal herb, ginkgo requires standardization for medicinal use; typically, a 50:1 extract of ginkgo leaf is used in ginkgo supplements. (NCI04)


The hydrochloride salt of bendamustine, a bifunctional mechlorethamine derivative with alkylator and antimetabolite activities. Bendamustine possesses three active moieties: an alkylating group; a benzimidazole ring, which may act as a purine analogue; and a butyric acid side chain. Although its exact mechanism of action is unknown this agent appears to act primarily as an alkylator. Bendamustine metabolites alkylate and crosslink macromolecules, resulting in DNA, RNA and protein synthesis inhibition, and, subsequently, apoptosis. Bendamustine may differ from other alkylators in that it may be more potent in activating p53-dependent stress pathways and inducing apoptosis; it may induce mitotic catastrophe; and it may activate a base excision DNA repair pathway rather than an alkyltransferase DNA repair mechanism. Accordingly, this agent may be more efficacious and less susceptible to drug resistance than other alkylators.


The hydrochloride salt form of arbutamine, a synthetic catecholamine with positive chronotropic and inotropic properties, used in echocardiography and diagnostic coronary angiography. Arbutamine binds to and activates beta-1 adrenergic receptors in the myocardium, thereby increasing heart rate and increasing force of myocardial contraction. By exerting a chronotropic and inotropic effect, arbutamine mimics the cardiac stress caused by exercise that may prevent adequate tissue perfusion and oxygenation, and may provoke myocardial ischemia in patients with coronary artery disease.


A lipid-soluble azo dye and sulfonamide antibacterial agent.


The hemihydrate form of estradiol, the most potent, naturally produced estrogen. Estradiol hemihydrate diffuses through the cell membrane and binds to and subsequently activates the nuclear estrogen receptor found in the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated complex binds to the estrogen response element on the DNA and activates the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics.


The hydrochloride salt form of tiagabine, a nipecotic acid derivative with anticonvulsant property. Tiagabine hydrochloride inhibits the gamma-aminobutyric acid (GABA) transporter type 1 (GAT1), which is predominantly localized in presynaptic terminals of neurons thereby preventing the reuptake of GABA by the presynaptic endings. Consequently, this increases the level of available GABA within the synaptic cleft, thereby resulting in prolongation of its inhibitory actions. Tiagabine is effective against maximum electroshock seizures and both limbic and generalized tonic-clonic seizures.


The mesylate salt form of eprosartan, a non-biphenyl, non-tetrazole, nonpeptide angiotensin II antagonist with antihypertensive activity. Eprosartan mesylate antagonizes angiotensin II type I receptors in tissues such as vascular smooth muscle and the adrenal gland. This prevents angiotensin II-induced vasoconstriction and prevents angiotensin II-mediated stimulation of aldosterone secretion by the adrenal cortex, which decreases the excretion of sodium and water and increases the excretion of potassium.


A nutritional supplement containing the zinc salt form of citric acid for the purpose of providing zinc. As an essential trace element, zinc is of key importance in many biological processes, acts as an antioxidant and strengthens the immune system. Although the mechanism of action is not completely known, zinc supplementation may be used to increase immunity against viruses or may interfere with the replication of certain viruses, such as the human papillomavirus (HPV).


The sodium salt form of ibandronic acid, a synthetic nitrogen-containing bisphosphonate. Ibandronic acid inhibits farnesyl pyrophosphate synthase, resulting in a reduction in geranylgeranyl GTPase signaling proteins and apoptosis of osteoclasts. This agent increases bone mineral density, decreases bone remodeling, inhibits osteoclast-mediated bone resorption, and reduces metastases-related and corticosteroid-related bone pain.


The oil extracted from the wood of the Camphor tree Cinnamomum Camphora. Camphor oil has anti-inflammatory and analgesic properties and is used for its aromatic properties, as an insect repellant, in embalming fluids, and in various topical skin preparations.


A racemic mixture of phenylalanine, an aromatic amino acid with antidepressant, analgesic and appetite suppressant properties. The antidepressant effect of DL-phenylalanine may be accounted for by its precursor role in the synthesis of the neurotransmitters norepinephrine and dopamine. Elevated brain norepinephrine and dopamine levels are thought to be associated with antidepressant effects. This agent also plays a role in alleviating mood swings of premenstrual syndrome (PMS), increasing energy and mental alertness and heighten the ability to focus in individuals with attention deficit hyperactivity disorder (ADHD).


Any synthetic therapeutic agent which is chemically identical to or similar to the endogenous human corticotropin-releasing factor (hCRF). Synthesized in the hypothalamus, hCRF stimulates the anterior pituitary gland to secrete adrenocorticotropic hormone (ACTH). In cerebral edema, hCRF acts by impeding the flow of fluid from blood vessels into brain tissue, thereby decreasing edema and stabilizing intracranial pressure. This agent possesses anti-edema properties independent of adrenal gland function. (NCI05)


An histamine H1 receptor antagonist without sedative activity. Epinastine hydrochloride blocks the histamine H1 receptor and inhibits the release of histamine from mast cells. This prevents the typical allergic symptoms that are caused by histamine activity on capillaries, skin, mucous membranes, and on gastrointestinal and bronchial smooth muscles. Typical histamine activities include vasodilation, bronchoconstriction, increased vascular permeability, pain, itching, and spasmodic contractions of gastrointestinal smooth muscles. Epinastine also has affinity for the histamine H2, 5-HT2, and the alpha-1, alpha-2 adrenergic receptors.


A thienopyridine with antiplatelet activity. Clopidogrel bisulfate irreversibly alters the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor, inhibiting ADP-mediated activation of the glycoprotein complex GPIIb/IIIa, and inhibiting fibrinogen binding to platelets and platelet adhesion and aggregation. (NCI04)


An antimony hydride and a mononuclear parent hydride that is used in many industrial processes. It is characterized as a toxic, colorless gas that is heavier than air with a disagreeable odor, and exposure occurs by inhalation, ingestion, or contact.


A yeast cell-derived recombinant polypeptide related to the naturally occurring, leech-derived anticoagulant hirudin. Lepirudin directly binds to and inactivates thrombin, producing dose-dependent increases in the activated partial thromboplastin time (aPTT) and prothrombin time (PT). The mechanism of action of this agent is independent of antithrombin III and is not inhibited by platelet factor 4. Natural hirudin, a family of highly homologous isopolypeptides, is produced in trace amounts by the leech Hirudo medicinalis.


The tartrate salt form of rivastigmine, a phenylcarbamate derivative exhibiting cognitive stimulating property. Although the mechanism of action has not been fully elucidated, rivastigmine tartrate may bind reversibly to cholinesterase, thereby decreasing the breakdown of acetylcholine and enhancing cholinergic function.


The benzoate salt form of rizatriptan, a member of the triptan class agents with anti-migraine property. Rizatriptan benzoate selectively binds to and activates serotonin (5-HT) 1B receptors expressed in intracranial arteries, and to 5-HT 1D receptors located on peripheral trigeminal sensory nerve terminals in the meninges and central terminals in brain stem sensory nuclei. Receptor binding results in constriction of cranial vessels and inhibition of nociceptive transmission, thereby providing relief of migraine headaches. Rizatriptan benzoate may also relief migraine headaches by inhibition of pro-inflammatory neuropeptide release.


Exudate from seeds of the grape plant Vitis vinifera, composed of oils and secondary plant metabolites (BIOFLAVONOIDS and polyphenols) credited with important medicinal properties.


A short-acting sympathomimetic beta-2 adrenergic receptor agonist with bronchodilator activity. Levalbuterol binds to beta-2 adrenergic receptors in bronchial smooth muscle and activates intracellular adenyl cyclase, an enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cAMP). Increased cAMP levels lead to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation of bronchial smooth muscles. The increased cAMP concentrations also inhibit the release of inflammatory mediators, especially from mast cells.


The hydrochloride salt form of levalbuterol, a relatively selective sympathomimetic beta-2 adrenergic receptor agonist with bronchodilator activity. Levalbuterol hydrochloride binds to beta-2 adrenergic receptors in bronchial smooth muscle and activates intracellular adenyl cyclase, thereby increasing the production of cyclic-3', 5'-adenosine monophosphate (cAMP). Increased cAMP levels lead to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation of bronchial smooth muscles. The increased cyclic AMP concentrations also inhibit the release of inflammatory mediators from mast cells.


theophylline 100 MG Extended Release Oral Tablet


procainamide HCl 100 MG/ML Injectable Solution

procainamide hydrochloride 100 MG/ML Injectable Solution


procainamide HCl 500 MG/ML Injectable Solution

procainamide hydrochloride 500 MG/ML Injectable Solution


hydrALAZINE HCl 20 MG per 1 ML Injection

hydralazine HCl 20 MG per 1 ML Injection

1 ML hydrALAZINE hydrochloride 20 MG/ML Injection

1 ML hydralazine hydrochloride 20 MG/ML Injection


reserpine 0.125 MG / chlorothiazide 250 MG Oral Tablet

chlorothiazide 250 MG / reserpine 0.125 MG Oral Tablet


clonidine hydrochloride 0.2 MG/Day Weekly Transdermal Patch

168 HR cloNIDine 0.00833 MG/HR Transdermal System

cloNIDine hydrochloride 0.2 MG/Day Weekly Transdermal Patch

clonidine HCl 0.2 MG/Day Weekly Transdermal System

cloNIDine HCl 0.2 MG/Day Weekly Transdermal System

168 HR clonidine 0.00833 MG/HR Transdermal System


papaverine hydrochloride 30 MG/ML Injectable Solution

papaverine HCl 30 MG/ML Injectable Solution


alprostadil 500 MCG in 1 ML Injection
alprostadil 500 MCG per 1 ML Injection


NaCl 30 MG/ML Inhalation Solution
sodium chloride 3 % Inhalation Solution

sodium chloride 30 MG/ML Inhalation Solution


sodium bicarbonate 7.5 % (44.6 MEQ) in 50 ML Prefilled Syringe

50 ML sodium bicarbonate 75 MG/ML Prefilled Syringe


1000 ML Pot Chloride 0.04 MEQ/ML / NaCl 9 MG/ML Injection

1000 ML potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection

potassium chloride 40 MEQ / sodium chloride 0.9 % in 1000 ML Injection

1000 ML K+ Chloride 0.04 MEQ/ML / NaCl 9 MG/ML Injection

potassium chloride 40 MEQ / sodium chloride 0.9 % per 1000 ML Injection


sodium acetate 2 MEQ/ML Injectable Solution


sodium chloride 3 % per 500 ML Injection

500 ML sodium chloride 30 MG/ML Injection


sodium chloride 5 % per 500 ML Injection

500 ML sodium chloride 50 MG/ML Injection


sodium lactate 50 MEQ per 10 ML Injection

sodium lactate 50 MEQ in 10 ML Injection


potassium acetate 2 MEQ/ML Injectable Solution

Pot Acetate 2 MEQ/ML Injectable Solution


potassium acetate 200 MEQ per 50 ML Injection

potassium acetate 200 MEQ in 50 ML Injection

50 ML potassium acetate 4 MEQ/ML Injection


K+ gluconate 2 MEQ Oral Tablet
potassium gluconate 2 MEQ Oral Tablet


calcium 600 MG Oral Tablet, as calcium carbonate

calcium carbonate 1500 MG (calcium 600 MG) Oral Tablet


zinc (as zinc chloride) 10 MG per 10 ML Injection


zinc gluconate 77 MG (zinc 10 MG) Oral Lozenge


zinc (as sulfate) 10 MG per 10 ML Injection


zinc (as sulfate) 25 MG per 5 ML Injection


manganese 1 MG (as manganese chloride 3.6 MG) per 10 ML Injection

10 ML manganese chloride 0.1 MG/ML Injection


manganese sulfate 1 MG in 10 ML Injection

manganese sulfate 1 MG per 10 ML Injection

10 ML manganese sulfate 0.1 MG/ML Injection


dextrose 40 % per 500 ML Injection
dextrose 40 % in 500 ML Injection


dextrose 50 % Injectable Solution
glucose 500 MG/ML Injectable Solution


vitamin C 60 MG Oral Lozenge
ascorbic acid 60 MG Oral Lozenge
vit-C 60 MG Oral Lozenge


ascorbic acid 1500 MG Extended Release Oral Tablet

vitamin C 1500 MG Extended Release Oral Tablet

vit-C 1500 MG Extended Release Oral Tablet


vitamin C 500 MG Oral Wafer
vit-C 500 MG Oral Wafer
ascorbic acid 500 MG Oral Wafer


ergocalciferol 8000 UNT (0.2 MG) per 1 ML Oral Solution

ergocalciferol 0.2 MG per 1 ML Oral Solution

ergocalciferol 200 MCG (8000 UNT) in 1 mL Oral Solution


vitamin E 180 MG (400 UNT) Oral Capsule
vitamin E 400 UNT Oral Capsule


vitamin E 180 MG (400 UNT) Chewable Tablet


vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

ascorbic acid 35 MG/mL / cholecalciferol 0.01 MG/mL / ferrous sulfate 50 MG/mL / niacin 8 MG/mL / riboflavin 0.6 MG/mL / thiamine 0.5 MG/mL / vitamin A 0.45 MG/mL / vitamin B6 0.4 MG/mL / vitamin E 2.25 MG/mL Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / FESO4 50 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

ascorbic acid 35 MG/ML / cholecalciferol 0.01 MG/ML / ferrous sulfate 50 MG/ML / niacin 8 MG/ML / riboflavin 0.6 MG/ML / thiamine 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution


vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / vit-B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

vit-C 35 MG/ML / cholecalciferol 0.01 MG/ML / vitamin B3 8 MG/ML / riboflavin 0.6 MG/ML / vitamin B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

ascorbic acid 35 MG/ML / cyanocobalamin 0.002 MG/ML / niacin 8 MG/ML / riboflavin 0.6 MG/ML / thiamine 0.5 MG/ML / vitamin A 1500 UNT/ML / vitamin B6 0.4 MG/ML / vitamin D 400 UNT/ML / vitamin E 5 UNT/ML Oral Solution

vitamin C 35 MG/ML / cholecalciferol 0.01 MG/ML / nicotinic acid 8 MG/ML / riboflavin 0.6 MG/ML / vit-B1 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution

ascorbic acid 35 MG/mL / cholecalciferol 0.01 MG/mL / niacin 8 MG/mL / riboflavin 0.6 MG/mL / thiamine 0.5 MG/mL / vitamin A 0.45 MG/mL / vitamin B12 0.002 MG/mL / vitamin B6 0.4 MG/mL / vitamin E 2.25 MG/mL Oral Solution

ascorbic acid 35 MG/ML / cholecalciferol 0.01 MG/ML / niacin 8 MG/ML / riboflavin 0.6 MG/ML / thiamine 0.5 MG/ML / vitamin A 0.45 MG/ML / vitamin B12 0.002 MG/ML / vitamin B6 0.4 MG/ML / vitamin E 2.25 MG/ML Oral Solution


cyanocobalamin 1000 MCG Extended Release Oral Tablet

cyanocobalamin 1 MG Extended Release Oral Tablet

vitamin B12 1 MG Extended Release Oral Tablet


cyanocobalamin 2 MG Extended Release Oral Tablet

cyanocobalamin 2000 MCG Extended Release Oral Tablet

vitamin B12 2 MG Extended Release Oral Tablet


cyanocobalamin 1000 MCG Sublingual Tablet


folate 5 MG/ML Injectable Solution
folic acid 5 MG/ML injectable Solution


leucovorin (as leucovorin calcium) 350 MG Injection

leucovorin 350 MG per 17.5 ML Lyophilized Powder for Injection


sodium thiosulfate 12.5 GM per 50 ML Injection

sodium thiosulfate 12.5 GM in 50 ML Injection

50 ML sodium thiosulfate 250 MG/ML Injection


activated charcoal / simethicone Oral Tablet


triamcinolone acetonide 0.1 % Oral Paste

triamcinolone acetonide 0.1 % Dental Paste

triamcinolone acetonide 1 MG per GM Oral Paste

triamcinolone acetonide 0.001 MG/MG Oral Paste


stannous fluoride 0.4 % (fluoride ion 0.16 % ) Oral Gel


citric acid / potassium bicarbonate / sodium bicarbonate Effervescent Oral Tablet


calcium carbonate 400 MG / magnesium hydroxide 135 MG in 5 mL Oral Suspension

calcium carbonate 400 MG / milk of magnesia 135 MG per 5 ML Oral Suspension

calcium carbonate 80 MG/ML / magnesium hydroxide 27 MG/ML Oral Suspension


calcium carbonate 420 MG (Ca 168) / simethicone 21 MG Chewable Tablet

calcium carbonate 420 MG / simethicone 21 MG Chewable Tablet


aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG in 5 mL Oral Suspension

aluminum hydroxide 400 MG / magnesium hydroxide 400 MG / simethicone 40 MG per 5 ML Oral Suspension

aluminum hydroxide 80 MG/ML / magnesium hydroxide 80 MG/ML / simethicone 8 MG/ML Oral Suspension

aluminum hydroxide 2400 MG / magnesium hydroxide 2400 MG / dimethicone 240 MG per 30 ML Oral Suspension

aluminum hydroxide 800 MG / magnesium hydroxide 800 MG / dimethicone 80 MG per 10 ML Oral Suspension


potassium bitartrate / sodium bicarbonate Rectal Suppository


estradiol 0.05 MG/Day Weekly Transdermal System

168 HR estradiol 0.00208 MG/HR Transdermal System

estradiol 0.05 MG/24HR Weekly Transdermal Patch


estradiol 0.1 MG/Day Weekly Transdermal System

estradiol 0.1 MG per 24 HR Weekly Transdermal Patch

168 HR estradiol 0.00417 MG/HR Transdermal System


estrogens, esterified (USP) 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet

estrogens, esterified 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet

estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet


medroxyPROGESTERone acetate 10 MG Oral Tablet

medroxyprogesterone acetate 10 MG Oral Tablet


medroxyPROGESTERone acetate 2.5 MG Oral Tablet

medroxyprogesterone acetate 2.5 MG Oral Tablet


medroxyPROGESTERone acetate 5 MG Oral Tablet

medroxyprogesterone acetate 5 MG Oral Tablet


ergonovine 0.2 MG/ML Injectable Solution


methylergonovine maleate 0.2 MG in 1 ML Injection

methylergonovine maleate 0.2 MG per 1 ML Injection

1 ML methylergonovine maleate 0.2 MG/ML Injection


carboprost tromethamine 250 MCG in 1 ML Injection


ethinyl estradiol 0.035 MG / norethindrone 0.4 MG Oral Tablet

norethindrone 0.4 MG / ethinyl estradiol 0.035 MG Oral Tablet


levonorgestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet

ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet


etidocaine hydrochloride 1 % Injectable Solution

etidocaine hydrochloride 10 MG/ML Injectable Solution


mepivacaine hydrochloride 20 MG/ML Injectable Solution


prilocaine hydrochloride 1 % Injectable Solution

prilocaine hydrochloride 10 MG/ML Injectable Solution


doxapram HCl 400 MG in 20 ML Injectable Solution

doxapram hydrochloride 20 MG/ML Injectable Solution

doxapram HCl 400 MG per 20 ML Injectable Solution


ketamine (as ketamine hydrochloride) 10 MG/ML Injectable Solution


ketamine (as ketamine hydrochloride) 100 MG/ML Injectable Solution


ketamine (as ketamine hydrochloride) 50 MG/ML Injectable Solution


PENTobarbital sodium 50 MG/ML Injectable Solution

pentobarbital sodium 50 MG/ML Injectable Solution


1 ML meperidine hydrochloride 75 MG/ML Injection


oxyCODONE 4.8355 MG / aspirin 325 MG Oral Tablet

aspirin 325 MG / oxyCODONE hydrochloride 4.84 MG Oral Tablet

ASA 325 MG / oxyCODONE hydrochloride 4.84 MG Oral Tablet

ASA 325 MG / oxycodone hydrochloride 4.8355 MG Oral Tablet

ASA 325 MG / oxyCODONE hydrochloride 4.8355 MG Oral Tablet

ASA 325 MG / oxycodone hydrochloride 4.84 MG Oral Tablet

aspirin 325 MG / oxycodone hydrochloride 4.84 MG Oral Tablet


buprenorphine 0.3 MG/ML (as buprenorphine HCl 0.324 MG/ML) Injection

buprenorphine HCl 0.3 MG in 1 ML Injection

buprenorphine HCl 0.3 MG per 1 ML Injection


butorphanol tartrate 1 MG in 1 ML Injection

butorphanol tartrate 1 MG per 1 ML Injection

1 ML butorphanol tartrate 1 MG/ML Injection


butorphanol tartrate 2 MG/ML Injectable Solution


pentazocine 30 MG/ML Injectable Solution

pentazocine (as pentazocine lactate) 30 MG/ML Injectable Solution


aspirin 325 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule

ASA 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule

butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Capsule


ASA 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet

aspirin 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet

butalbital 50 MG / aspirin 325 MG / caffeine 40 MG Oral Tablet


acetaminophen / aspirin / caffeine / salicylamide Oral Tablet


acetaminophen / aspirin / caffeine Oral Tablet


mesalazine 66.7 MG/ML Enema
mesalamine 4 GM per 60 ML Enema
mesalamine 4 GM per 60 mL Enema


acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule

APAP 325 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule

butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Capsule


APAP 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet

acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet

butalbital 50 MG / acetaminophen 325 MG / caffeine 40 MG Oral Tablet


acetaminophen 500 MG in 5 mL Oral Solution

acetaminophen 80 MG per 0.8 ML Oral Solution

acetaminophen 500 MG per 5 ML Oral Solution


dihydroergotamine mesylate 1 MG per 1 ML Injection

dihydroergotamine mesylate 1 MG in 1 ML Injection

1 ML dihydroergotamine mesylate 1 MG/ML Injection


naloxone hydrochloride 0.02 MG/ML Injectable Solution


naloxone hydrochloride 0.4 MG/ML Injectable Solution

naloxone HCl 0.4 MG/ML Injectable Solution


naloxone hydrochloride 1 MG/ML Injectable Solution


phenytoin sodium 250 MG in 5 ML Injection

5 ML phenytoin sodium 50 MG/ML Injection

phenytoin sodium 250 MG per 5 ML Injection


benztropine mesylate 2 MG per 2 ML Injection

benztropine mesylate 2 MG in 2 ML Injection

2 ML benztropine mesylate 1 MG/ML Injection


methocarbamol 1000 MG per 10 ML Injection

methocarbamol 1000 MG in 10 ML Injection


succinylcholine chloride 20 MG/ML Injectable Solution


physostigmine salicylate 1 MG/ML in 2 ML Injection

physostigmine salicylate 1 MG/ML per 2 ML Injection

2 ML physostigmine salicylate 1 MG/ML Injection


pyridostigmine bromide 10 MG in 2 ML Injection

pyridostigmine bromide 10 MG per 2 ML Injection

2 ML pyridostigmine bromide 5 MG/ML Injection


edrophonium chloride 10 MG/ML Injectable Solution

edrophonium Cl 10 MG/ML Injectable Solution


atropine sulfate 1 MG per 2.5 ML Injectable Solution

atropine sulfate 0.4 MG/ML Injectable Solution

atropine sulfate 1.2 MG per 3 ML Injectable Solution

atropine sulfate 2 MG per 5 ML Injectable Solution


atropine sulfate 1 MG per 1 ML Injection


hyoscyamine sulfate 0.5 MG in 1 ML Injection

hyoscyamine sulfate 0.5 MG per 1 ML Injection

1 ML hyoscyamine sulfate 0.5 MG/ML Injection


glycopyrrolate 0.2 MG/ML Injectable Solution


5 ML DOPamine hydrochloride 160 MG/ML Injection

dopamine HCl 160 MG/ML per 5 ML Injection

DOPamine HCl 160 MG/ML per 5 ML Injection

5 ML dopamine hydrochloride 160 MG/ML Injection

DOPamine HCl 160 MG/ML in 5 ML Injection


5 ML dopamine hydrochloride 40 MG/ML Injection

DOPamine HCl 40 MG/ML per 5 ML Injection

5 ML DOPamine hydrochloride 40 MG/ML Injection

dopamine HCl 40 MG/ML per 5 ML Injection


DOPamine HCl 80 MG/ML in 10 ML Injection

dopamine HCl 80 MG/ML per 10 ML Injection

DOPamine HCl 80 MG/ML per 10 ML Injection

10 ML DOPamine hydrochloride 80 MG/ML Injection

10 ML dopamine hydrochloride 80 MG/ML Injection


dextroamphetamine sulfate 10 MG Oral Tablet


dextroamphetamine sulfate 5 MG Oral Tablet


methoxamine 20 MG/ML Injectable Solution


ritodrine hydrochloride 10 MG/ML Injectable Solution


phenylephrine hydrochloride 100 MG per 10 ML Injectable Solution

phenylephrine hydrochloride 50 MG per 5 ML Injectable Solution

phenylephrine hydrochloride 10 MG/ML Injectable Solution

phenylephrine HCl 10 MG/ML Injectable Solution

phenylephrine hydrochloride 1 % Injectable Solution


mephentermine 30 MG/ML Injectable Solution


labetalol HCl 5 MG/ML Injectable Solution

labetalol hydrochloride 5 MG/ML Injectable Solution


1 ML propranolol hydrochloride 1 MG/ML Injection

propranolol hydrochloride 1 MG per ML Injection


propranolol hydrochloride 80 MG/ML Oral Solution


metoprolol tartrate 5 MG per 5 ML Injection

5 ML metoprolol tartrate 1 MG/ML Injection

metoprolol tartrate 5 MG in 5 ML Injection


esmolol hydrochloride 250 MG/ML Injectable Solution


hyaluronidase 1500 UNT/ML Injectable Solution


zinc oxide 25 % Topical Ointment
ZNO 0.25 MG/MG Topical Ointment


salicylic acid 100 MG/ML Topical Solution


sodium hydroxide 100 MG/ML Topical Solution


methyl salicylate 250 MG/ML Topical Cream


selenium sulfide 1 % / menthol 0.5 % Medicated Shampoo

menthol 0.5 % / selenium sulfide 1 % Medicated Shampoo

menthol 5 MG/ML / selenium sulfide 10 MG/ML Medicated Shampoo


selenium sulfide 25 MG/ML Medicated Shampoo

selenium sulfide 2.5 % Medicated Shampoo

selenium sulfide 2.5 % Topical Suspension


6-aminocaproic acid 250 MG/ML Injectable Solution


tranexamic acid 1000 MG in 10 ML Injection

tranexamic acid 1000 MG per 10 ML Injection

10 ML tranexamic acid 100 MG/ML Injection


desmopressin acetate 0.004 MG/ML Injectable Solution

desmopressin acetate 4 MCG/ML Injectable Solution


levothyroxine sodium 0.025 MG Oral Tablet


levothyroxine sodium 0.05 MG Oral Tablet


levothyroxine sodium 0.075 MG Oral Tablet


levothyroxine sodium 125 MCG Oral Tablet

levothyroxine sodium 0.125 MG Oral Tablet


levothyroxine sodium 0.15 MG Oral Tablet

levothyroxine sodium 150 MCG Oral Tablet


hydrocortisone 2.5 % Injectable Suspension

hydrocortisone 25 MG/ML Injectable Suspension


hydrocortisone sodium succinate 100 MG Injection

hydrocortisone (as hydrocortisone sodium succinate) 100 MG Injection


methylPREDNISolone acetate 20 MG/ML Injectable Suspension

methylprednisolone acetate 20 MG/ML Injectable Suspension


methylPREDNISolone acetate 80 MG/ML Injectable Suspension

methylprednisolone acetate 80 MG/ML Injectable Suspension


An enema solution containing 5% glycerin, a trihydroxy alcohol with osmotic laxative activity. Upon rectal administration, glycerin enema creates an osmotic gradient thereby attracting water into the rectum. This increases volume, increases peristalsis, stimulates evacuation, and relieves constipation.


benzethonium chloride 1 MG/ML Medicated Liquid Soap

benzethonium chloride 0.1 % Medicated Liquid Soap


povidone-iodine 10 % Medicated Liquid Soap

povidone-iodine 100 MG/ML Medicated Liquid Soap


benzocaine 20 % Oral Gel
benzocaine 0.2 MG/MG Oral Gel

benzocaine 20 % (180-220 MG per 1 GM) Oral Gel


betamethasone 0.5 MG/ML Topical Cream
betamethasone 0.05 % Topical Cream

betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Cream


bacitracin / neomycin / polymyxin B Topical Ointment


acetylcholine chloride 20 MG per 2 ML (1 % ) Intraocular Solution

acetylcholine chloride 20 MG in 2 mL Ophthalmic Solution

acetylcholine chloride 10 MG/ML Ophthalmic Solution


bacitracin / neomycin / polymyxin B Ophthalmic Ointment


tetrahydrozoline hydrochloride 0.1 % Nasal Solution

tetrahydrozoline hydrochloride 1 MG/ML Nasal Solution

tetrahydrozoline HCl 0.1 % Nasal Solution


naphazoline hydrochloride 0.5 MG/ML Nasal Solution

naphazoline hydrochloride 0.05 % Nasal Solution


xylometazoline HCl 0.05 % Nasal Solution

xylometazoline hydrochloride 0.05 % Nasal Solution

xylometazoline hydrochloride 0.5 MG/ML Nasal Solution


oxymetazoline hydrochloride 0.25 MG/ML Nasal Solution

oxymetazoline HCl 0.025 % Nasal Solution

oxymetazoline hydrochloride 0.025 % Nasal Solution


oxymetazoline hydrochloride 0.5 MG/ML Nasal Solution

oxymetazoline hydrochloride 0.05 % Nasal Drops

oxymetazoline hydrochloride 0.05 % Nasal Solution


phenylephrine hydrochloride 1.25 MG/ML Nasal Spray


phenylephrine hydrochloride 0.125 % Nasal Solution

phenylephrine HCl 0.125 % Nasal Solution

phenylephrine hydrochloride 1.25 MG/ML Nasal Solution


phenylephrine hydrochloride 0.5 % Nasal Solution

phenylephrine hydrochloride 5 MG/ML Nasal Solution


phenylephrine hydrochloride 1 % Nasal Solution

phenylephrine hydrochloride 10 MG/ML Nasal Solution


glycerin 30 MG/ML / NaCl 7.5 MG/ML Nasal Solution

glycerin 3 % / sodium chloride 0.75 % Nasal Solution

glycerin 30 MG/ML / sodium chloride 7.5 MG/ML Nasal Solution


ammonium chloride 100 MEQ in 20 ML Injection

ammonium chloride 100 MEQ per 20 ML Injection

20 ML ammonium chloride 5 MEQ/ML Injection


Monobasic Pot phosphate 0.0408 MEQ/ML Oral Solution

Monobasic K+ phosphate 0.0408 MEQ/ML Oral Solution

monobasic potassium phosphate 0.0408 MEQ/ML Oral Solution


pancuronium bromide 1 MG/ML Injectable Solution


pancuronium bromide 2 MG/ML Injectable Solution


atracurium besylate 10 MG/ML Injectable Solution


fluorouracil (as fluorouracil sodium) 50 MG/ML Injectable Solution

5-5-fluorouracil 50 MG/ML Injectable Solution

fluorouracil 2.5 GM per 50 ML Injectable Solution


vinBLAStine sulfate 1 MG/ML Injectable Solution

vinblastine sulfate 1 MG/ML Injectable Solution


dactinomycin 0.5 MG Injection
DACTINomycin 500 MCG Injection
DACTINomycin 0.5 MG Injection


piperacillin (as piperacillin sodium) 200 MG/ML Injectable Solution

piperacillin 200 MG/ML Injectable Solution


ampicillin (as ampicillin sodium) 100 MG/ML Injectable Solution

ampicillin 100 MG/ML Injectable Solution


nafcillin (as nafcillin sodium) 100 MG/ML Injectable Solution


nafcillin (as nafcillin sodium) 1 GM Injection


amoxicillin 250 MG per 5 ML Oral Suspension

amoxicillin (as amoxicillin trihydrate) 250 MG per 5 ML Oral Suspension

amoxicillin 250 MG in 5 mL Oral Suspension


chloramphenicol (as chloramphenicol sodium succinate) 1 GM per 10 ML Powder for Injectable Solution

chloramphenicol 100 MG/ML Injectable Solution


gentamicin sulfate 20 MG in 2 ML Injection

gentamicin (as gentamicin sulfate) 20 MG per 2 ML Injection


netilmicin (as netilmicin sulfate) 100 MG/ML Injectable Solution

netilmicin 100 MG/ML Injectable Solution


capreomycin 500 MG/ML Injectable Solution

capreomycin (as capreomycin sulfate) 500 MG/ML Injectable Solution


vancomycin (as vancomycin hydrochloride) 100 MG/ML Injectable Solution

vancomycin 100 MG/ML Injectable Solution


lincomycin 300 MG/ML Injectable Solution

lincomycin (as lincomycin HCl) 300 MG/ML Injectable Solution


methenamine hippurate 1000 MG Oral Tablet


methenamine mandelate 500 MG Oral Tablet


griseofulvin 125 MG in 5 mL Oral Suspension

griseofulvin 125 MG per 5 ML Oral Suspension


muromonab-CD3 5 MG per 5 ML Injectable Solution

muromonab-CD3 1 MG/ML Injectable Solution


epoetin alfa 2000 UNT per 1 ML Injection

1 ML ERYTHROPOIETIN 2000 UNT/ML Injection


epoetin alfa 4000 UNT per 1 ML Injection

1 ML ERYTHROPOIETIN 4000 UNT/ML Injection


epoetin alfa 10,000 UNT/ML Injectable Solution

ERYTHROPOIETIN 10000 UNT/ML Injectable Solution

epoetin alfa 10000 UNT/ML Injectable Solution


cholecalciferol 125 MCG (5000 UNT) Oral Capsule


potassium gluconate 595 MG (potassium 99 MG) Oral Tablet


zidovudine 10 MG per 1 ML Oral Solution
AZT 10 MG/ML Oral Solution
zidovudine 10 MG in 1 mL Oral Solution


acetaminophen 500 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet

APAP 500 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet

butalbital 50 MG / acetaminophen 500 MG / caffeine 40 MG Oral Tablet


norgestimate 0.25 MG / ethinyl estradiol 0.035 MG Oral Tablet

ethinyl estradiol 35 MCG / norgestimate 0.25 MG Oral Tablet

ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet


benzethonium chloride 0.1 % / benzocaine 20 % Topical Ointment

benzethonium chloride 0.001 MG/MG / benzocaine 0.2 MG/MG Topical Ointment


betamethasone 0.5 MG/ML (betamethasone dipropionate 0.64 MG/ML) Topical Lotion

betamethasone dipropionate 0.05 % Topical Lotion


1 ML ERYTHROPOIETIN 3000 UNT/ML Injection

epoetin alfa 3000 UNT per 1 ML Injection


fluocinolone acetonide 0.01 % Medicated Shampoo

fluocinolone acetonide 0.1 MG/ML Medicated Shampoo


NaCl 0.154 MEQ/ML Topical Spray
sodium chloride 0.9 % Topical Spray

sodium chloride 0.154 MEQ/ML Topical Spray


crude coal tar 2.5 % (coal tar solution 12.5 % ) Medicated Shampoo


cefTAZidime (as cefTAZidime pentahydrate) 250 MG/ML Injectable Solution

ceftazidime (as ceftazidime pentahydrate) 250 MG/ML Injectable Solution

cefTAZidime 250 MG/ML Injectable Solution

ceftazidime 250 MG/ML Injectable Solution


interferon gamma-1b 2,000,000 UNT per 0.5 ML Injection

interferon gamma-1b 0.1 MG per 0.5 ML Injection

interferon gamma-1b 100 MCG in 0.5 ML Injection

interferon gamma-1b 100 MCG per 0.5 ML Injection

0.5 ML interferon gamma-1b 0.2 MG/ML Injection


filgrastim 300 MCG per 1 ML Injection
filgrastim 300 MCG in 1 ML Injection


colloidal oatmeal 10 MG/ML Topical Lotion


magnesium gluconate 550 MG (magnesium 30 MG) Oral Tablet


cyanocobalamin 1500 MCG Extended Release Oral Tablet

cyanocobalamin 1.5 MG Extended Release Oral Tablet

vitamin B12 1.5 MG Extended Release Oral Tablet


glycolate 70 % Topical Solution
glycolic acid 70 % Topical Solution


salicylic acid 0.4 MG/MG Medicated Patch


betamethasone dipropionate 0.05 % Topical Gel

betamethasone 0.5 MG/GM (betamethasone dipropionate 0.64 MG/GM) Topical Gel


isoniazid / pyrazinamide / rifAMPin Oral Tablet

isoniazid / pyrazinamide / rifampin Oral Tablet


magnesium sulfate 10 GM per 500 ML Injection

magnesium sulfate 10 GM in 500 ML Injection

500 ML magnesium sulfate 20 MG/ML Injection


magnesium sulfate 1 GM per 100 ML Injection

magnesium sulfate 1 GM in 100 ML Injection

100 ML magnesium sulfate 10 MG/ML Injection


vecuronium bromide 1 MG/ML Injectable Solution


benzocaine / chloroxylenol Topical Ointment


sodium hyaluronate 14 MG/ML Injectable Solution


NaCl 0.000154 MEQ/MG Topical Gel
sodium chloride 0.9 % Topical Gel

sodium chloride 0.000154 MEQ/MG Topical Gel


sodium chloride 20 % Topical Gel
NaCl 0.00342 MEQ/MG Topical Gel

sodium chloride 0.00342 MEQ/MG Topical Gel


oxacillin 2 GM per 50 ML Injection
oxacillin 2 GM in 50 ML Injection


colloidal oatmeal 1 % Topical Cream
Avena sativa 1 % Topical Cream

colloidal oatmeal 10 MG/ML Topical Cream


sodium fluoride 0.05 % (fluoride ion 0.02 % ) Oral Rinse


desogestrel 0.15 MG / ethinyl estradiol 0.03 MG Oral Tablet


caffeine 250 MG/ML / sodium benzoate 250 MG/ML per 2 ML Injection

caffeine / sodium benzoate 250 MG/ML (caffeine 125 MG/ML) in 2 ML Injection

2 ML caffeine 125 MG/ML / sodium benzoate 125 MG/ML Injection


clarithromycin 125 MG in 5 mL Oral Suspension

clarithromycin 125 MG per 5 ML Oral Suspension


cladribine 10 MG in 10 ML Injection
cladribine 10 MG per 10 ML Injection


calcium citrate 1040 MG (Ca 250 MG) Oral Tablet

calcium citrate 1040 MG (calcium 250 MG) Oral Tablet


mepivacaine hydrochloride 10 MG/ML Injectable Solution

mepivacaine hydrochloride 1 % Injectable Solution


sodium nitroprusside 25 MG/ML per 2 ML Injection

sodium nitroprusside 50 MG in 2 ML Injection

sodium nitroprusside 50 MG per 2 ML Injection

2 ML sodium nitroprusside 25 MG/ML Injection


adenosine triphosphate 20 MG Delayed Release Oral Tablet


dexbrompheniramine maleate 2 MG Oral Tablet


chlorpheniramine tannate 4 MG per 5 ML Oral Suspension

chlorpheniramine tannate 0.8 MG/ML Oral Suspension


vitamin E acetate 30 UNT Rectal Suppository


pegaspargase 3750 UNT per 5 ML Injection


granisetron HCl 1 MG/ML Injectable Solution

granisetron 1 MG (as granisetron HCl 1.12 MG) per ML Injectable Solution


ampicillin (as ampicillin sodium) 100 MG/ML / sulbactam (as sulbactam sodium) 50 MG/ML Injectable Solution

ampicillin 100 MG/ML / sulbactam 50 MG/ML Injectable Solution

ampicillin (as ampicillin sodium) 10 GM / sulbactam (as sulbactam sodium) 5 GM per 100 ML Injectable Solution

ampicillin 100 MG / sulbactam 50 MG per ML Injectable Solution


phenylephrine hydrochloride 10 MG Chewable Tablet


benzethonium chloride 0.2 % Topical Foam

benzethonium chloride 2 MG/ML Topical Foam


dyphylline 100 MG / guaiFENesin 100 MG per 15 ML Elixir

dyphylline 100 MG / guaifenesin 100 MG per 15 ML Elixir

dyphylline 6.67 MG/ML / guaifenesin 6.67 MG/ML Oral Solution

dyphylline 6.67 MG/ML / guaiFENesin 6.67 MG/ML Oral Solution

dyphylline 100 MG / guaiFENesin 100 MG per 15 ML Oral Solution

dyphylline 100 MG / guaifenesin 100 MG per 15 ML Oral Solution


hypromellose 4 MG/ML Ophthalmic Solution


chlorhexidine gluconate 20 % Topical Solution

chlorhexidine gluconate 200 MG/ML Topical Solution


pamidronate disodium 60 MG per 10 ML Injection

pamidronate disodium 60 MG in 10 ML Injection

10 ML pamidronate disodium 6 MG/ML Injection


estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 5 MG Oral Tablet

estrogens, conjugated 0.625 MG / medroxyPROGESTERone acetate 5 MG Oral Tablet

estrogens, conjugated (USP) 0.625 MG / medroxyPROGESTERone acetate 5 MG Oral Tablet


estrogens, conjugated 0.625 MG / medroxyPROGESTERone acetate 2.5 MG Oral Tablet

estrogens, conjugated (USP) 0.625 MG / medroxyPROGESTERone acetate 2.5 MG Oral Tablet

estrogens, conjugated (USP) 0.625 MG / medroxyprogesterone acetate 2.5 MG Oral Tablet


abciximab 10 MG in 5 ML Injection
abciximab 10 MG per 5 ML Injection


calcium 250 MG / fluoride 3 MG Oral Tablet, as calcium carbonate and sodium monofluorophosphate

calcium carbonate 625 MG / sodium monofluorophosphate 22.8 MG Oral Tablet


estradiol 0.075 MG/Day Weekly Transdermal System

168 HR estradiol 0.00312 MG/HR Transdermal System

estradiol 0.075 MG/Day Weekly Transdermal Patch


ubidecarenone 60 MG Oral Tablet
coenzyme Q10 60 MG Oral Tablet


diphenhydrAMINE HCl 12.5 MG Chewable Tablet

diphenhydrAMINE hydrochloride 12.5 MG Chewable Tablet

diphenhydramine hydrochloride 12.5 MG Chewable Tablet


Pot Hydroxide 100 MG/ML Topical Solution

potassium hydroxide 10 % Topical Solution

potassium hydroxide 100 MG/ML Topical Solution


{10 (20 ML ifosfamide 50 MG/ML Injection) / 10 (mesna 100 MG/ML Injectable Solution) } Pack

ifosfamide kit (10 vials (ifosfamide 1 GM in 20 ML Injection) / 10 vials (mesna 20 MG/ML in 10 ML)) Injectable Solution

{10 vials (ifosfamide 1 GM per 20 ML Injection) / 10 vials 10 ML (mesna 20 MG/ML (concentrate 100 MG/ML)) Injectable Solution} Kit


hydromorphone HCl 10 MG per 1 ML Injection

1 ML hydromorphone hydrochloride 10 MG/ML Injection

HYDROmorphone HCl 10 MG per 1 ML Injection

1 ML HYDROmorphone hydrochloride 10 MG/ML Injection

HYDROmorphone HCl 10 MG in 1 ML Injection


cyclosporine, modified 100 MG Oral Capsule

cycloSPORINE, modified 100 MG Oral Capsule


acetaminophen 650 MG / phenyltoloxamine citrate 50 MG Oral Tablet

APAP 650 MG / phenyltoloxamine citrate 50 MG Oral Tablet


brompheniramine maleate 2 MG / phenylephrine HCl 5 MG per 5 ML Oral Syrup

brompheniramine maleate 2 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Syrup

brompheniramine maleate 0.4 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution


84 HR estradiol 0.00156 MG/HR Transdermal System

estradiol 37.5 MCG/Day Twice Weekly Transdermal Patch

estradiol 0.00156 MG/HR 84 HR Transdermal Patch

estradiol 0.0375 MG/Day Twice Weekly Transdermal System


phosphatidyl choline 1200 MG Oral Capsule


dilTIAZem hydrochloride 100 MG Injection

diltiazem hydrochloride 100 MG Injection


ERYTHROPOIETIN 20000 UNT/ML Injectable Solution

epoetin alfa 20,000 UNT/ML Injectable Solution

epoetin alfa 20000 UNT/ML Injectable Solution


gemcitabine (as gemcitamine HCl) 1 GM Injection


ibutilide fumarate 1 MG per 10 ML Injection

ibutilide fumarate 1 MG (equivalent to ibutilide 0.087 MG) per 10 ML Injection

ibutilide fumarate 1 MG in 10 ML Injection

10 ML ibutilide fumarate 0.1 MG/ML Injection


melatonin 3 MG Extended Release Oral Tablet


insulin lispro 100 UNT/ML Injectable Solution

insulin, analog lispro 100 UNT/ML Injectable Solution


salicylic acid 50 MG/ML Medicated Shampoo


fosphenytoin sodium 150 MG (as PE 100 MG) per 2 ML Injection

fosphenytoin sodium 100 MG PE per 2 ML Injection

2 ML fosphenytoin sodium 75 MG/ML Injection

fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 100 MG per 2 ML) Injection


milk of magnesia 311 MG Oral Tablet
magnesium hydroxide 311 MG Oral Tablet


dehydroepiandrosterone 25 MG Oral Capsule


20 ML levoFLOXacin 25 MG/ML Injection
levofloxacin 500 MG per 20 ML Injection
levoFLOXacin 500 MG per 20 ML Injection
20 ML levofloxacin 25 MG/ML Injection


glatiramer acetate 20 MG/ML Injectable Solution


etomidate 20 MG per 10 ML Injection
etomidate 20 MG in 10 ML Injection


tetracaine hydrochloride 20 MG/ML Topical Cream


levonorgestrel 0.1 MG / ethinyl estradiol 0.02 MG Oral Tablet

ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet


dextromethorphan HBr 10 MG / guaifenesin 100 MG / phenylephrine HCl 5 MG per 5 ML Oral Solution

dextromethorphan HBr 10 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG per 5 ML Oral Solution

dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 10 mL Oral Solution

dextromethorphan HBr 20 MG / guaifenesin 200 MG / phenylephrine HCl 10 MG per 10 ML Oral Solution

dextromethorphan hydrobromide 2 MG/ML / guaiFENesin 20 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution

dextromethorphan HBr 20 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG per 10 ML Oral Solution

dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution


phenazopyridine hydrochloride 97.5 MG Oral Tablet


estradiol 0.025 MG/24HR Weekly Transdermal Patch

estradiol 0.025 MG/Day Weekly Transdermal System

168 HR estradiol 0.00104 MG/HR Transdermal System


dehydroepiandrosterone 50 MG Oral Capsule


cyanocobalamin 50 MCG Oral Lozenge
vitamin B12 50 MCG Oral Lozenge
cyanocobalamin 0.05 MG Oral Lozenge


potassium iodide 325 MG per 5 ML Oral Solution

potassium iodide 325 MG in 5 mL Oral Solution


50 ML riTUXimab 10 MG/ML Injection
riTUXimab 500 MG in 50 ML Injection
50 ML rituximab 10 MG/ML Injection
riTUXimab 500 MG per 50 ML Injection


montelukast 5 MG (as montelukast sodium 5.2 MG) Chewable Tablet


ascorbic acid 75 MG / cyanocobalamin 0.015 MG / ferrous fumarate 333 MG / folic acid 0.5 MG / liver stomach concentrate 240 MG Oral Capsule

vitamin C 75 MG / ferrous fumarate 333 MG / folate 0.5 MG / liver stomach concentrate 240 MG / vitamin B12 0.015 MG Oral Capsule

vit-C 75 MG / ferrous fumarate 333 MG / folate 0.5 MG / liver stomach concentrate 240 MG / vitamin B12 0.015 MG Oral Capsule

ascorbic acid 75 MG / ferrous fumarate 333 MG / folic acid 0.5 MG / liver stomach concentrate 240 MG / vitamin B12 0.015 MG Oral Capsule


dextromethorphan HBr 12.5 MG in 5 mL Oral Solution

dextromethorphan hydrobromide 2.5 MG/ML Oral Solution


dilTIAZem hydrochloride 120 MG 24 HR Extended Release Oral Tablet

24 HR diltiazem hydrochloride 120 MG Extended Release Oral Tablet

dilTIAZem hydrochloride 120 MG 24HR Extended Release Oral Tablet

24 HR dilTIAZem hydrochloride 120 MG Extended Release Oral Tablet

diltiazem hydrochloride 120 MG 24 HR Extended Release Oral Tablet


iron (as ferrous gluconate) 27 MG Oral Tablet

ferrous gluconate 240 MG (iron 27 MG) Oral Tablet


The oil rendered from the shin bones and feet of cattle. Neatsfoot oil is used primarily as a conditioning, softening, and preservative agent for leather.


dextromethorphan HBr 15 MG / guaiFENesin 300 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution

dextromethorphan HBr 15 MG / guaifenesin 300 MG / phenylephrine HCl 10 MG per 5 ML Oral Solution

dextromethorphan hydrobromide 3 MG/ML / guaiFENesin 60 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution

dextromethorphan HBr 15 MG / guaiFENesin 300 MG / phenylephrine HCl 10 MG per 5 ML Oral Solution

dextromethorphan hydrobromide 3 MG/ML / guaifenesin 60 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution


calcium carbonate 550 MG / milk of magnesia 110 MG Chewable Tab

calcium carbonate 550 MG (Ca 220 MG) / magnesium hydroxide 110 MG Chewable Tablet

calcium carbonate 550 MG / magnesium hydroxide 110 MG Chewable Tablet


levocarnitine 1 GM per 5 ML Injection
5 ML levOCARNitine 200 MG/ML Injection
5 ML levocarnitine 200 MG/ML Injection
levOCARNitine 1 GM in 5 ML Injection


estradiol 0.00208 MG / norethindrone acetate 0.00583 MG per HR 84 HR Transdermal Patch

84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.00583 MG/HR Transdermal System

estradiol 0.05 MG / norethindrone acetate 0.14 MG per Day Twice Weekly Transdermal Patch

estradiol 50 MCG / norethindrone acetate 140 MCG/Day Twice Weekly Transdermal System


vitamin C 250 MG / Iron Carbonyl 100 MG Oral Tablet

iron carbonyl 100 MG / vitamin C 250 MG Oral Tablet

iron carbonyl (as iron) 100 MG / ascorbic acid 250 MG Oral Tablet

vit-C 250 MG / Iron Carbonyl 100 MG Oral Tablet

ascorbic acid 250 MG / iron carbonyl 100 MG Oral Tablet


triclosan 0.3 GM per 100 GM Medicated Bar Soap

triclosan 0.003 MG/MG Medicated Bar Soap


estradiol 50 MCG / norethindrone acetate 250 MCG/Day Twice Weekly Transdermal System

estradiol 0.00208 MG / norethindrone acetate 0.0104 MG per HR 84 HR Transdermal Patch

estradiol 0.05 MG / norethindrone acetate 0.25 MG per Day Twice Weekly Transdermal Patch

84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System


abacavir (as abacavir sulfate) 300 MG Oral Tablet


abacavir 20 MG/ML Oral Solution
abacavir 20 MG in 1 mL Oral Solution

abacavir (as abacavir sulfate) 20 MG per 1 ML Oral Solution


lamiVUDine 5 MG in 1 mL Oral Solution
lamiVUDine 5 MG/ML Oral Solution
3TC 5 MG/ML Oral Solution
lamivudine 5 MG per 1 ML Oral Solution
lamiVUDine 5 MG per 1 ML Oral Solution


dextrose 30 % in 500 ML Injection
dextrose 30 % per 500 ML Injection


vitamin B12 1000 MCG Oral Lozenge
cyanocobalamin 1000 MCG Oral Lozenge
cyanocobalamin 1 MG Oral Lozenge


epoetin alfa 40,000 UNT in 1 ML Injection

epoetin alfa 40,000 UNT per 1 ML Injection

1 ML ERYTHROPOIETIN 40000 UNT/ML Injection

1 ML epoetin alfa 40000 UNT/ML Injection


acetaminophen 400 MG / HYDROcodone bitartrate 5 MG Oral Tablet

APAP 400 MG / Hydrocodone Bitartrate 5 MG Oral Tablet

APAP 400 MG / HYDROcodone Bitartrate 5 MG Oral Tablet

HYDROcodone bitartrate 5 MG / acetaminophen 400 MG Oral Tablet

acetaminophen 400 MG / hydrocodone bitartrate 5 MG Oral Tablet


APAP 400 MG / HYDROcodone Bitartrate 7.5 MG Oral Tablet

HYDROcodone bitartrate 7.5 MG / acetaminophen 400 MG Oral Tablet

APAP 400 MG / Hydrocodone Bitartrate 7.5 MG Oral Tablet

acetaminophen 400 MG / HYDROcodone bitartrate 7.5 MG Oral Tablet

acetaminophen 400 MG / hydrocodone bitartrate 7.5 MG Oral Tablet


verapamil HCl 100 MG 24HR Extended Release Oral Capsule

verapamil hydrochloride 100 MG 24 HR Extended Release Oral Capsule

24 HR verapamil hydrochloride 100 MG Extended Release Oral Capsule


diflorasone diacetate 0.05 % Topical Cream

diflorasone diacetate 0.5 MG/ML Topical Cream


metronidazole 7.5 MG/ML Topical Lotion
metroNIDAZOLE 7.5 MG/ML Topical Lotion
metronidazole 0.75 % Topical Lotion


levalbuterol 1.25 MG (as levalbuterol HCl 1.44 MG) per 3 ML Inhalation Solution

levalbuterol HCl 1.25 MG in 3 ML Inhalation Solution

levalbuterol 0.417 MG/ML Inhalation Solution


sodium ferric gluconate complex (as elemental iron) 62.5 MG per 5 ML Injection

sodium ferric gluconate complex (as iron) 62.5 MG in 5 mL Injection

5 ML sodium ferric gluconate complex 12.5 MG/ML Injection


cephradine 250 MG/ML Injectable Solution


ceftazidime 6 GM per 30 ML Injectable Solution

ceftazidime 200 MG/ML Concentrate for Injectable Solution

cefTAZidime 6 GM per 30 ML Injectable Solution

cefTAZidime 200 MG/ML Injectable Solution

cefTAZidime 200 MG/ML Concentrate for Injectable Solution

ceftazidime 200 MG/ML Injectable Solution


minocycline (as minocycline hydrochloride) 10 MG/ML Oral Suspension


gentamicin sulfate 100 MG in 100 ML Injection

gentamicin (as gentamicin sulfate) 100 MG per 100 ML Injection


tobramycin (as tobramycin sulfate) 60 MG per 50 ML Injection


quiNINE sulfate 200 MG Oral Tablet
quiNINE 200 MG Oral Tablet


mumps virus vaccine live, Jeryl Lynn strain 40000 UNT/ML Injectable Solution


Crotalidae polyvalent immune Fab (ovine) (equivalent to 1 GM total protein) Injection

Agkistrodon piscivorus antivenin / Crotalus adamanteus antivenin / Crotalus atrox antivenin / Crotalus scutulatus antivenin (equivalent to 1 GM total protein) Injection

Agkistrodon piscivorus antivenin 780 UNT / Crotalus adamanteus antivenin 420 UNT / Crotalus atrox antivenin 1270 UNT / Crotalus scutulatus antivenin 5570 UNT Injection


Micrurus fulvius antivenin 100 MG/ML Injectable Solution

North American coral snake antivenin 100 MG/ML Injectable Solution


estradiol 0.00208 MG/HR 84 HR Transdermal Patch

estradiol 0.05 MG/Day Twice Weekly Transdermal System

estradiol 50 MCG/Day Twice Weekly Transdermal Patch

84 HR estradiol 0.00208 MG/HR Transdermal System


estradiol 0.1 MG/24HR Twice Weekly Transdermal Patch

estradiol 0.00417 MG/HR 84 HR Transdermal Patch

84 HR estradiol 0.00417 MG/HR Transdermal System

estradiol 0.1 MG/Day Twice Weekly Transdermal System


insulin, protamine zinc, beef 100 UNT/ML Injectable Suspension


NTG 0.02 MG/MG Topical Ointment
nitroglycerin 2 % Topical Ointment
TNG 0.02 MG/MG Topical Ointment

nitroglycerin 0.02 MG/MG Topical Ointment


norepinephrine (as bitartrate) 4 MG per 4 ML Injection

norepinephrine bitartrate 4 MG in 4 mL Injection


cholestyramine resin 4 GM Powder for Oral Suspension

cholestyramine resin 4000 MG Powder for Oral Suspension

cholestyramine resin 4 GM per 9 GM Powder for Oral Suspension


triprolidine hydrochloride 1.25 MG in 5 mL Oral Solution

triprolidine hydrochloride 1.25 MG per 5 ML Oral Solution

triprolidine hydrochloride 0.25 MG/ML Oral Solution


ephedrine hydrochloride 0.5 % Nasal Solution

ePHEDrine hydrochloride 0.5 % Nasal Solution

ePHEDrine hydrochloride 5 MG/ML Nasal Solution

ephedrine hydrochloride 5 MG/ML Nasal Solution


cromolyn sodium 5.2 MG/ACTUAT Nasal Spray


dextromethorphan HBr 30 MG / pseudoephedrine HCl 60 MG Oral Capsule

dextromethorphan hydrobromide 30 MG / pseudoephedrine hydrochloride 60 MG Oral Capsule


casanthranol 30 MG per 5 ML Oral Solution


danthron 50 MG / docusate sodium 60 MG Oral Capsule

danthron 50 MG / DOSS Sodium 60 MG Oral Capsule


aluminum hydroxide 1200 MG / magnesium hydroxide 1200 MG per 30 ML Oral Suspension

aluminum hydroxide 200 MG / milk of magnesia 200 MG per 5 ML Oral Suspension

aluminum hydroxide 200 MG / magnesium hydroxide 200 MG in 5 mL Oral Suspension

aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML Oral Suspension


atropine sulfate 0.3 MG/ML Injectable Solution


benzquinamide 25 MG/ML Injectable Solution


amylase 20,000 UNT / lipase 5000 UNT / protease 20,000 UNT Oral Capsule

amylases 20,000 UNT / endopeptidases 20,000 UNT / lipase 5000 UNT Oral Capsule

amylase 20000 UNT / lipase 5000 UNT / protease 20000 UNT Oral Capsule


methenamine mandelate 100 MG/ML Oral Suspension


methenamine mandelate 300 MG / sodium phosphate 500 MG Oral Tablet


benzocaine 5 % / resorcinol 2 % Vaginal Cream

benzocaine 50 MG/ML / resorcinol 20 MG/ML Vaginal Cream


oxyquinoline sulfate 0.025 % / sodium lauryl sulfate 0.01 % Vaginal Gel

oxyquinoline sulfate 0.00025 MG/MG / sodium dodecyl sulfate 0.0001 MG/MG Vaginal Gel


APAP 650 MG / diphenhydrAMINE hydrochloride 50 MG Oral Tablet

acetaminophen 650 MG / diphenhydrAMINE hydrochloride 50 MG Oral Tablet

APAP 650 MG / diphenhydramine hydrochloride 50 MG Oral Tablet

acetaminophen 650 MG / diphenhydrAMINE HCl 50 MG Oral Tablet

acetaminophen 650 MG / diphenhydramine hydrochloride 50 MG Oral Tablet


acetaminophen 80 MG per 0.8 ML Oral Suspension

acetaminophen 160 MG per 1.6 ML Oral Suspension

acetaminophen 80 MG in 0.8 mL Oral Suspension


aspirin 421 MG / caffeine 32 MG Oral Tablet


acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet

APAP 194 MG / ASA 227 MG / caffeine 33 MG Oral Tablet


phenylbutazone 1000 MG Oral Bolus
phenylbutazone 1 GM Oral Tablet


5 ML lidocaine hydrochloride 40 MG/ML Injection


vit-B3 1000 MG Oral Tablet
nicotinic acid 1000 MG Oral Tablet
niacin 1000 MG Oral Tablet


vitamin C 60 MG/ML Drops
vit-C 60 MG/ML Oral Solution
vitamin C 60 MG/ML Oral Solution


sodium fluoride 0.44 MG/ML Oral Solution


sodium chloride 600 MG Extended Release Oral Tablet

NaCl 600 MG Extended Release Oral Tablet


ZnSO4 50 MG Oral Capsule
zinc sulfate 50 MG Oral Capsule


dextrose 2.5 % / sodium chloride 0.45 % Injectable Solution

dextrose 2.5 GM / NaCl 450 MG in 100 ML Injectable Solution

glucose 25 MG/ML / sodium chloride 0.0769 MEQ/ML Injectable Solution

Glucose 25 MG/ML / NaCl 0.0769 MEQ/ML Injectable Solution


dextrose 10 % / sodium chloride 0.45 % in 1000 ML Injection

1000 ML Glucose 100 MG/ML / NaCl 4.5 MG/ML Injection

dextrose 10 % / sodium chloride 0.45 % per 1000 ML Injection

1000 ML glucose 100 MG/ML / sodium chloride 4.5 MG/ML Injection


cyanocobalamin 2 MG Oral Tablet
cyanocobalamin 2000 MCG Oral Tablet


ferrous sulfate 250 MG Extended Release Oral Tablet

FESO4 250 MG Extended Release Oral Tablet


dextran 40 10 % in 5 % dextrose per 500 ML Injection

dextran 40 10 % in 0.9 % sodium chloride per 500 ML Injection


epinephrine 0.1 % Ophthalmic Solution
EPINEPHrine 0.1 % Ophthalmic Solution
EPINEPHrine 1 MG/ML Ophthalmic Solution


A solution intended for irrigation of the eye.


eugenol 85 % Dental Solution
eugenol 85 % Topical Solution


pramoxine HCl 1 % Rectal Foam
pramoxine hydrochloride 1 % Rectal Foam

pramoxine hydrochloride 10 MG/ML Rectal Foam


benzoyl peroxide 50 MG / erythromycin 30 MG per GM Topical Gel

erythromycin 3 % / benzoyl peroxide 5 % Topical Gel

benzoyl peroxide 5 % / erythromycin 3 % Topical Gel

benzoyl peroxide 0.05 MG/MG / erythromycin 0.03 MG/MG Topical Gel


benzoyl peroxide 5 % / hydrocortisone 0.5 % Topical Lotion

benzoyl peroxide 50 MG/ML / hydrocortisone 5 MG/ML Topical Lotion


benzoic acid 6 % / salicylic acid 3 % Topical Cream

benzoic acid 60 MG/ML / salicylic acid 30 MG/ML Topical Cream


diphenhydramine HCl 1 % / tripelennamine HCl 0.5 % Topical Gel

diphenhydrAMINE hydrochloride 0.01 MG/MG / tripelennamine hydrochloride 0.005 MG/MG Topical Gel

diphenhydrAMINE HCl 1 % / tripelennamine HCl 0.5 % Topical Gel

diphenhydramine hydrochloride 0.01 MG/MG / tripelennamine hydrochloride 0.005 MG/MG Topical Gel


camphor 0.3 % / menthol 0.3 % Topical Gel

camphor 0.003 MG/MG / menthol 0.003 MG/MG Topical Gel


zinc pyrithione 20 MG/ML Medicated Shampoo


coal tar 5 % / salicylic acid 3 % Topical Cream

coal tar 50 MG/ML / salicylic acid 30 MG/ML Topical Cream


betamethasone (as betamethasone benzoate) 0.25 MG/ML Topical Cream

betamethasone benzoate 0.025 % Topical Cream


hydrocortisone acetate 10 MG/ML / pramoxine hydrochloride 10 MG/ML Topical Foam

hydrocortisone acetate 1 % / pramoxine hydrochloride 1 % Topical Foam

hydrocortisone acetate 1 % / pramoxine HCl 1 % Topical Foam


hydrocortisone acetate 1 % / pramoxine hydrochloride 1 % Topical Ointment

hydrocortisone acetate 1 % / pramoxine HCl 1 % Topical Ointment

hydrocortisone acetate 0.01 MG/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment


hydrocortisone acetate 2.5 % / pramoxine hydrochloride 1 % Topical Ointment

hydrocortisone acetate 2.5 % / pramoxine HCl 1 % Topical Ointment

hydrocortisone acetate 0.025 MG/MG / pramoxine hydrochloride 0.01 MG/MG Topical Ointment


salicylic acid 126 MG/ML Topical Solution


lactic acid 167 MG / salicylic acid 167 MG per 1 GM Topical Gel

lactic acid 16.7 % / salicylic acid 16.7 % Topical Gel

lactic acid 0.167 MG/MG / salicylic acid 0.167 MG/MG Topical Gel


salicylic acid 2 % / sulfur 3 % Topical Cream

salicylic acid 20 MG/ML / sulfur 30 MG/ML Topical Cream


lidocaine hydrochloride 2.5 % Topical Solution

lidocaine hydrochloride 25 MG/ML Topical Solution


lidocaine hydrochloride 2 % Topical Spray

lidocaine hydrochloride 20 MG/ML Topical Spray


lidocaine hydrochloride 0.05 MG/MG Topical Ointment

lidocaine hydrochloride 5 % Ointment for Oral and Topical Administration

lidocaine hydrochloride 50 MG per GM Ointment for Oral and Topical Administration

lidocaine hydrochloride 0.05 MG/MG Ointment for Oral and Topical Administration


benzocaine 6.3 % / phenol 0.5 % Topical Solution

benzocaine 63 MG/ML / phenol 5 MG/ML Topical Solution


aluminum chloride 250 MG/ML Topical Solution


ZnO 20 % Topical Lotion
zinc oxide 20 % Topical Lotion
ZNO 200 MG/ML Topical Lotion


ZNO 0.4 MG/MG Topical Ointment
zinc oxide 0.4 MG/MG Topical Ointment


chlorhexidine gluconate 0.12 % Mouthwash

chlorhexidine gluconate 1.2 MG/ML Mouthwash

chlorhexidine gluconate 0.12 % Oral Rinse


Polymyxin B 10000 UNT/ML / TMP 1 MG/ML Ophthalmic Solution

polymyxin B sulfate 10,000 UNT / trimethoprim sulfate 1 MG in ML Ophthalmic Solution

polymyxin B 10000 UNT/ML / trimethoprim 1 MG/ML Ophthalmic Solution

polymyxin B 10,000 UNT / trimethoprim 0.1 % Ophthalmic Solution

polymyxin B 10,000 UNT / trimethoprim (as trimethoprim sulfate) 0.1 % Ophthalmic Solution


aluminum hydroxide 254 MG / magnesium carbonate 237.5 MG per 5 ML Oral Suspension

aluminum hydroxide 254 MG / magnesium carbonate 237.5 MG in 5 mL Oral Suspension

aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension


ferrous sulfate 168 MG (iron 50 MG) Extended Release Oral Tablet

ferrous sulfate 168 MG Extended Release Oral Tablet

FESO4 168 MG Extended Release Oral Tablet


dextromethorphan HBr 5 MG / pseudoephedrine HCl 15 MG per 5 ML Oral Solution

dextromethorphan 5 MG / pseudoephedrine 15 MG per 5 ML Oral Solution

dextromethorphan hydrobromide 1 MG/ML / pseudoephedrine hydrochloride 3 MG/ML Oral Solution


calcium acatate 1000 MG (calcium 250 MG) Oral Tablet

calcium acetate 1 GM (Ca 250 MG) Oral Tablet


fentanyl 25 MCG/HR 72HR Transdermal System

fentaNYL 25 MCG/HR 3 Day Transdermal Patch

72 HR fentaNYL 0.025 MG/HR Transdermal System

fentaNYL 25 MCG/HR 72HR Transdermal System

fentanyl 25 MCG/HR 3 Day Transdermal Patch

72 HR fentanyl 0.025 MG/HR Transdermal System


fentanyl 50 MCG/HR 72HR Transdermal System

72 HR fentanyl 0.05 MG/HR Transdermal System

72 HR fentaNYL 0.05 MG/HR Transdermal System

fentaNYL 50 MCG/HR 72HR Transdermal System

fentanyl 50 MCG/HR 3 Day Transdermal Patch

fentaNYL 50 MCG/HR 3 Day Transdermal Patch


fentanyl 100 MCG/HR 72HR Transdermal System

fentanyl 100 MCG/HR 3 Day Transdermal Patch

fentaNYL 100 MCG/HR 72HR Transdermal System

72 HR fentaNYL 0.1 MG/HR Transdermal System

72 HR fentanyl 0.1 MG/HR Transdermal System

fentaNYL 100 MCG/HR 3 Day Transdermal Patch


codeine phosphate 10 MG / chlorpheniramine maleate 2 MG / phenylephrine HCl 5 MG in 5 mL Oral Solution

chlorpheniramine maleate 2 MG / codeine phosphate 10 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution

chlorpheniramine maleate 0.4 MG/ML / codeine phosphate 2 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution


activated charcoal 400 MG / simethicone 80 MG Oral Tablet


dextrose 10 % / sodium chloride 0.2 % per 250 ML Injection

dextrose 10 % / sodium chloride 0.2 % in 250 ML Injection

250 ML Glucose 100 MG/ML / NaCl 2 MG/ML Injection

250 ML glucose 100 MG/ML / sodium chloride 2 MG/ML Injection


diphenhydrAMINE hydrochloride 20 MG/ML Topical Solution

diphenhydrAMINE HCl 2 % Topical Solution

diphenhydrAMINE hydrochloride 2 % Topical Solution

diphenhydramine hydrochloride 2 % Topical Solution

diphenhydramine hydrochloride 20 MG/ML Topical Solution


cefuroxime (as cefuroxime sodium) 250 MG/ML Injectable Suspension

cefuroxime 250 MG/ML Injectable Suspension


netilmicin (as netilmicin sulfate) 50 MG/ML Injectable Solution


insulin isophane, human 85 UNT/ML / insulin, regular, human 15 UNT/ML Injectable Suspension


insulin, human mixed 50/50 100 UNT/ML Injectable Suspension

insulin isophane, human 50 UNT/ML / insulin, regular, human 50 UNT/ML Injectable Suspension


ergonovine 0.5 MG/ML Injectable Solution


NTG 1 MG/ML Injectable Solution
TNG 1 MG/ML Injectable Solution

nitroglycerin 1 MG/ML Injectable Solution


albuterol (as albuterol sulfate) 5 MG/ML Inhalation Solution

albuterol 1 MG/ML (concentrate 5 MG/ML) Inhalation Solution

albuterol 1 MG/ML (concentrate 0.5 % ) Inhalation Solution

albuterol 2.5 MG per 0.5 ML Concentrate for Inhalation Solution

albuterol 0.5 % Concentrate for Inhalation Solution


EPINEPHrine (as EPINEPHrine bitartrate) 0.5 MG/ML Injectable Solution

EPINEPHrine 0.5 MG/ML Injectable Solution

epinephrine 0.5 MG/ML Injectable Solution

epinephrine (as epinephrine bitartrate) 0.5 MG/ML Injectable Solution


aminophylline 350 MG Extended Release Oral Tablet


aluminum hydroxide 500 MG / milk of magnesia 500 MG per 5 ML Oral Suspension

aluminum hydroxide 100 MG/ML / magnesium hydroxide 100 MG/ML Oral Suspension


atropine sulfate 0.6 MG/ML Injectable Solution


scopolamine 0.6 MG/ML Injectable Solution


chlorproMAZINE hydrochloride 20 MG/ML Oral Suspension

chlorproMAZINE hydrochloride (as chlorproMAZINE embonate) 20 MG/ML Oral Suspension

chlorpromazine hydrochloride (as chlorpromazine embonate) 20 MG/ML Oral Suspension

chlorpromazine hydrochloride 20 MG/ML Oral Suspension


fluPHENAZine decanoate 100 MG/ML Injectable Solution

fluphenazine decanoate 100 MG/ML Injectable Solution


trifluoperazine (as trifluoperazine hydrochloride) 1 MG/ML Oral Solution


methotrimeprazine 2.5 % Injectable Solution

methotrimeprazine 25 MG/ML Injectable Solution


MS 50 MG Oral Tablet
morphine sulfate 50 MG Oral Tablet


oxycodone hydrochloride 10 MG Oral Tablet

oxyCODONE hydrochloride 10 MG Oral Tablet


niacinamide 500 MG Extended Release Oral Tablet


vitamin C 1000 MG Oral Capsule
ascorbic acid 1000 MG Oral Capsule
vit-C 1000 MG Oral Capsule


ascorbic acid 125 MG Chewable Tablet
vit-C 125 MG Chewable Tablet
vitamin C 125 MG Chewable Tablet


vit-C 25 MG Oral Lozenge
ascorbic acid 25 MG Oral Lozenge
vitamin C 25 MG Oral Lozenge


vitamin D3 25 MCG (1000 UNT) Oral Capsule


cyanocobalamin 1000 MCG Oral Capsule
cyanocobalamin 1 MG Oral Capsule


chloramphenicol 0.25 % Ophthalmic Solution

chloramphenicol (as chloramphenicol sodium) 2.5 MG/ML Ophthalmic Solution

chloramphenicol 2.5 MG/ML Ophthalmic Solution


sodium fluoride 5 % Dental Solution
sodium fluoride 5 % Mouthwash


sodium fluoride 2.09 % (fluoride ion 1.23 % ) Dental Gel

sodium fluoride 2 % (fluoride ion 1.23 % ) Dental Gel


sodium fluoride 0.22 % (fluoride 0.1 % ) Toothpaste


sulfur 5 % / resorcinol 2 % Topical Lotion

resorcinol 2 % / sulfur 5 % Topical Lotion

resorcinol 20 MG/ML / sulfur 50 MG/ML Topical Lotion


allantoin 2 % / coal tar 5 % Topical Cream

coal tar 5 % / allantoin 2 % Topical Cream

allantoin 20 MG/ML / coal tar 50 MG/ML Topical Cream


coal tar 5 % / allantoin 2 % Topical Lotion

allantoin 2 % / coal tar 5 % Topical Lotion

allantoin 20 MG/ML / coal tar 50 MG/ML Topical Lotion


flurandrenolide 0.125 MG/ML Topical Cream


flurandrenolide 0.0125 % Topical Ointment

flurandrenolide 0.000125 MG/MG Topical Ointment


salicylic acid 2.5 MG/ML Topical Solution


lidocaine hydrochloride 0.5 % Topical Gel

lidocaine hydrochloride 0.005 MG/MG Topical Gel


lidocaine hydrochloride 1 % Topical Gel
lidocaine HCl 1 % Topical Gel

lidocaine hydrochloride 0.01 MG/MG Topical Gel


zinc oxide 15 % Topical Cream
ZNO 150 MG/ML Topical Cream


zinc oxide 15 % Topical Ointment
ZNO 0.15 MG/MG Topical Ointment


hydrogen peroxide 350 MG/ML Topical Solution


sodium hypochlorite 10 MG/ML Topical Solution


hydrocortisone butyrate 0.1 % Topical Lotion

hydrocortisone butyrate 1 MG/ML Topical Lotion


amdinocillin pivoxil HCl 200 MG Oral Tablet


lidocaine hydrochloride 1 % / methylPREDNISolone acetate 4 % Injectable Suspension

lidocaine hydrochloride 10 MG/ML / methylPREDNISolone acetate 40 MG/ML Injectable Suspension

lidocaine hydrochloride 1 % / methylprednisolone acetate 4 % Injectable Suspension

lidocaine hydrochloride 10 MG/ML / methylprednisolone acetate 40 MG/ML Injectable Suspension


danthron 25 MG / poloxamer-188 200 MG Oral Capsule

danthron 25 MG / poloxamer 188 200 MG Oral Capsule


danthron 25 / poloxamer 188 200 in 5 mL Oral Suspension

danthron 5 MG/ML / poloxamer 188 40 MG/ML Oral Suspension


pipothiazine 50 MG/ML Injectable Solution


prochlorperazine (as prochlorperazine edisylate) 1 MG/ML Oral Solution

prochlorperazine (as prochlorperazine mesylate) 1 MG/ML Oral Solution


acenocoumarol 1 MG Oral Tablet
nicoumalone 1 mg oral tablet


clioquinol 1 % / flumethasone 0.02 % Otic Solution

clioquinol 10 MG/ML / flumethasone 0.2 MG/ML Otic Solution


econazole nitrate 1 % / hydrocortisone 1 % Topical Cream

hydrocortisone 1 % / econazole nitrate 1 % Topical Cream

econazole nitrate 10 MG/ML / hydrocortisone 10 MG/ML Topical Cream


naftidrofuryl oxalate 100 MG Oral Capsule


clomiPRAMINE HCl 75 MG Extended Release Oral Tablet

clomiPRAMINE hydrochloride 75 MG Extended Release Oral Tablet

clomipramine hydrochloride 75 MG Extended Release Oral Tablet


clomiPRAMINE hydrochloride 12.5 MG/ML Injectable Solution

clomipramine hydrochloride 12.5 MG/ML Injectable Solution


cisapride (as cisapride monohydrate) 1 MG/ML Oral Suspension


SMX 80 MG/ML / TMP 16 MG/ML Oral Suspension

sulfamethoxazole 80 MG/ML / trimethoprim 16 MG/ML Oral Suspension


cloNIDine hydrochloride 0.015 % Injectable Solution

clonidine hydrochloride 0.015 % Injectable Solution

cloNIDine hydrochloride 0.15 MG/ML Injectable Solution

clonidine hydrochloride 0.15 MG/ML Injectable Solution


24 HR hydroCHLOROthiazide 12.5 MG / metoprolol succinate 100 MG Extended Release Oral Tablet

HCTZ 12.5 MG / metoprolol succinate 100 MG (as metoprolol succinate 95 MG equivalent to metoprolol tartrate 100 MG) 24 HR Extended Release Oral Tablet

24 HR HCTZ 12.5 MG / metoprolol succinate 100 MG Extended Release Oral Tablet

metoprolol succinate 100 MG / hydroCHLOROthiazide 12.5 MG 24HR Extended Release Oral Tablet

HCTZ 12.5 MG / metoprolol succinate 100 MG 24 HR Extended Release Oral Tablet

24 HR hydrochlorothiazide 12.5 MG / metoprolol succinate 100 MG Extended Release Oral Tablet


aMILoride hydrochloride 2.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet

Amiloride Hydrochloride 2.5 MG / HCTZ 25 MG Oral Tablet

aMILoride HCl 2.5 MG / hydroCHLOROthiazide 25 MG Oral Tablet

aMILoride Hydrochloride 2.5 MG / HCTZ 25 MG Oral Tablet

amiloride hydrochloride 2.5 MG / hydrochlorothiazide 25 MG Oral Tablet


amoxicillin (as amoxicillin trihydrate) 100 MG/ML Oral Suspension


phenytoin sodium 100 MG Oral Tablet
DPH sodium 100 MG Oral Tablet


phytonadione 10 MG Oral Tablet
vitamin K1 10 MG Oral Tablet


penicillin G benzathine 900000 UNT/ML / penicillin G procaine 300000 UNT/ML Injectable Suspension


norethindrone enanthate 200 MG/ML Injectable Solution


aMILoride hydrochloride 5 MG / furosemide 40 MG Oral Tablet

aMILoride HCl 5 MG / furosemide 40 MG Oral Tablet

amiloride hydrochloride 5 MG / furosemide 40 MG Oral Tablet


spironolactone 50 MG / furosemide 20 MG Oral Capsule

furosemide 20 MG / spironolactone 50 MG Oral Capsule


ASA 100 MG Oral Tablet
aspirin 100 MG Oral Tablet


traMADol hydrochloride 50 MG/ML Injectable Solution

tramadol hydrochloride 50 MG/ML Injectable Solution


buprenorphine (as buprenorphine hydrochloride) 0.2 MG Sublingual Tablet


netilmicin (as netilmicin sulfate) 10 MG/ML Injectable Solution


ethinyl estradiol 0.05 MG / levonorgestrel 0.25 MG Oral Tablet


fluphenazine hydrochloride 0.5 MG / nortriptyline (as nortriptyline hydrochloride) 10 MG Oral Tablet

fluPHENAZine hydrochloride 0.5 MG / nortriptyline (as nortriptyline hydrochloride) 10 MG Oral Tablet

fluPHENAZine HCl 500 MCG / nortriptyline 10 MG Oral Tablet

fluPHENAZine hydrochloride 0.5 MG / nortriptyline 10 MG Oral Tablet

fluphenazine hydrochloride 0.5 MG / nortriptyline 10 MG Oral Tablet


ethinyl estradiol 30 MCG / gestodene 75 MCG Oral Tablet

ethinyl estradiol 0.03 MG / gestodene 0.075 MG Oral Tablet


hydrocortisone 1 % / miconazole nitrate 2 % Topical Cream

hydrocortisone 10 MG/ML / miconazole nitrate 20 MG/ML Topical Cream


potassium nitrate 25 % / silver nitrate 75 % Topical Swab

potassium nitrate 25 % / silver nitrate 75 % Medicated Pad

potassium nitrate 25 % / silver nitrate 75 % Topical Stick

potassium nitrate 25 % / silver nitrate 75 % Topical Sponge

Pot nitrate 250 MG/ML / AgNO3 750 MG/ML Medicated Pad

K+ nitrate 250 MG/ML / AgNO3 750 MG/ML Medicated Pad

potassium nitrate 250 MG/ML / silver nitrate 750 MG/ML Medicated Pad